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ABSTRACT
Software for Sequence Analysis of Variants in Functional Screening Libraries and Personalized
Genome Files
By
Jacklyn Newsome
Dr. Martin Schiller, Thesis Committee Chair
Professor of Cell and Molecular Biology
University of Nevada, Las Vegas

Detailed knowledge of protein function is critical for both the study of protein interactions and the
development of drugs which target specific proteins. Currently, there are few techniques that directly
examine protein function. The techniques that are available are time consuming and can only address
one variant of a protein at a time. Our laboratory has designed 3 high throughput protein function
screens. We hypothesize that these will address this shortfall.
The first screen is the Chimeric Minimotif Decoy (CMD) Assay. For this screen, we constructed red
fluorescent proteins with one or more C-terminal minimotifs. Minimotifs are short, contiguous amino
acid sequences with a known function. These CMD proteins are then over-expressed in a cell, which is
then infected with HIV. HIV relies on host proteins to replicate. The minimotifs of the protein may
competitively bind the host proteins as a decoy and inhibit HIV infection. HIV infection is indicated by
the expression of a green fluorescent protein transcribed from an LTR-GFP HIV infection reporter
construct.
The second technique we developed is the GigaAssay Driver Mutagenesis Screen. With this screen, the
effects of all single mutations on a protein’s ability to function can be comprehensively examined. The
screen is constructed by using a CRISPR-Cas9 system to integrate the GigaAssay cassette into a cell. This
cassette includes a randomly mutagenized variant of a driver protein and a reporter protein. The

iii

sequences of both of these proteins share a DNA barcode sequence that is unique to that cell. In our
proof-of-concept experiment, the driver protein is Tat, the transcription factor responsible for the
replication of the HIV-1 genome. Here, Tat drives the transcription of the reporter, GFP. The strength of
each variant of Tat can be determined by the ratio between the reporter and driver mRNA transcripts.
Our third technique is the GigaAssay MD screen. Here, the GigaAssay cassette has a CMD protein
sequence and an LTR-GFP HIV infection reporter sequence, and the CMD sequence and reporter
sequence share a unique barcode. The CMD protein’s ability to inhibit HIV infection can be determined
by the ratio between the CMD and reporter mRNA transcripts.
However, the large amount of nucleic acid sequencing data produced by these screens cannot be
interpreted by any currently existing analysis pipelines. The goal of my thesis was to optimize the
construction of proteins for the Chimeric Minimotif Decoy assay and to write and validate a suite of Java
software to interpret and visualize the results of all of the screens (Table 1). The software I wrote
correctly interprets the sequence of 100% of the CMD proteins in the CMD Assay. It also correctly
interprets 98.6% of synthetic test transcript sequences in the GigaAssay Driver Mutagenesis Screen and
98.9% of synthetic test transcript sequences in the GigaAssay MD Screen.
I also wrote and validated a suite of Java software for the generation of personalized dietary
recommendations based on meta-analysis of nutrigenetics studies. Nutrigenetics is the study of the
effect of genetic variation on the response of phenotypes and phenotypic risk to diet and dietary
changes. The software first composes a dataset by comparing our laboratory’s meta-analysis data with
the USDA Nutrient Database, matching foods to recommendations, and calculating recommended food
portions. The software then builds a MySQL database with this dataset. This database is then used by
the software to analyze a user’s personal genome file and match variants in the file to dietary
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recommendations, which are then exported to a personalized dietary suggestion report. The software
correctly builds the MySQL database and matches genome file variants accurately in all test cases.

Table 1.1: A Brief Summary of the Software that I Wrote
Software
Suite
CMD Screen
Analysis
Software

GigaAssay
Analysis
Software

Nutrigenetics
Report
Generation
Software

Program Name

Description

Programming
Language

CMD-1

Identifies the minimotif sequences of Chimeric
Minimotif Decoy Screen library clones

JavaTM

CMD-2

Generates inhibition metric graphs for all
experimental minimotifs

R

Giga-G

Generates simulated test sequences for validation of
Giga-D & Giga-MD

JavaTM

Giga-D

Analyzes the RNA-Seq data from the GigaAssay
Driver Mutagenesis Screen

JavaTM / R

Giga-MD

Analyzes the RNA-Seq data from the GigaAssay
Minimotif Decoy Screen

JavaTM / R

Nutrigenetics-D

Creates MySQL database from a nutrigenetics
dataset and the USDA Nutrient Database

JavaTM

Nutrigenetics-R

Generates personal dietary suggestion reports by
comparing commercial raw genome data with
information in MySQL database

JavaTM

v

ACKNOWLEDGMENTS
I would like to thank Dr. Martin Schiller for his role as my advisor for the last 2 years. I would
also like to thank my committee members Dr. Ernesto Abel-Santos, Dr. Nora Caberoy, and Dr.
Mira Han for the time that they have dedicated. I would like to thank Dr. Ronald Benjamin
Babu, our post-doc, and Surbhi Sharma, the world’s hardest working PhD student, for all of
their help throughout this process. Lastly, I would like to thank my parents, Jeff and Kathleen
Newsome, my sister, Jeanne, and my loving partner Christopher Ashmus for their continual
support and patience. I’d also like to thank Xiangxue Xiao for her help with the statistics and my
cousins, Mark and Pat Moran, for helping me to understand how a hash map actually works.

vi

TABLE OF CONTENTS
ABSTRACT .................................................................................................................................... iii
ACKNOWLEDGEMENTS ……………………………………........................................................................ vi
LIST OF TABLES ........................................................................................................................... ix
LIST OF FIGURES ………………………………………………………………………………………………………………………. x
LIST OF EQUATIONS …………………….………………………………………………………………………………………… xiii
CHAPTER 1: THE CHIMERIC MINIMOTIF DECOY ASSAY ............................................................... 1
1.1 ABSTRACT ……………..……………………………………………………………………………………………………… 1
1.2 INTRODUCTION ……………………………………………………..………………………………………………………. 2
1.2.1 The CMD Screen ……………………………………………….…………………………………………………. 3
1.2.2 Optimizing Construction of the CMD Clone Library ………………………….………………… 10
1.2.3 The CMD Sequence Analysis Software Overview ……………………………….………………. 13
1.3 METHODS …………………………………………………………………………………………………………………….. 15
1.3.1 Construction of The CMD Library ………………………………………………………………………. 15
1.4 RESULTS ……………………………………………………………………………………………………………………….. 21
1.4.1 Library Construction Optimization …………….………………………………………………………. 21
1.4.2 The CMD Sequence Analysis Software – CMD-1 & CMD-2 .………………………....……. 22
1.4.3 CMD Clone Sequence Analysis Program (CMD-1 & CMD-2) Validation ..………….… 27
1.5 DISCUSSION ………………………………………………………………………………………………………………….. 31
1.6 REFERENCES …………………………………………………………………………………………………………………. 33
CHAPTER 2: THE GIGAASSAY……………………………………………………………………………………………..…… 36
2.1 ABSTRACT …………………………………………………………………………………………………………………..… 36
2.2 INTRODUCTION ……………………………………………………………………………………………………………. 38
2.2.1 The GigaAssay Driver Mutagenesis Screen ………….………………………………………………. 40
2.2.2 The GigaAssay MD Screen …………………………………………………………………………………… 44
2.2.3 GigaAssay Software Overview …………………………….………………………………………………. 45
2.3 METHODS …………………………………………………………………………………………………………………….. 44
2.3.1 Giga-G: Sequence Generation Program ….…………………………………….………………………. 44
2.3.2 Giga-D: GigaAssay Sequence Analysis Software Driver Mutagenesis Mode ….…….… 54
2.3.3 Statistics ……………………………………………………………….……………………………………………… 61
2.3.4 Giga-MD: Software for the GigaAssay Minimotif Decoy (MD) Screen ………………...… 64
2.4 RESULTS ……………………………………………………………………………………………..……………………….. 67
2.4.1 GigaAssay Driver Mutagenesis Sequence Generation and Interpretation …..……..… 67
vii

2.4.2 GigaAssay Minimotif Decoy (MD) Assay Sequence Generation and
Interpretation ………………….………………………………………………………………………………..... 74
2.5 DISCUSSION ………….………………………………………………………………………………………………..….. 78
2.6 REFERENCES ……………………………………………………………………………………………………………….. 81
CHAPTER 3: The Nutrigenetics Project Software ………………………………………………………………….. 85
3.1 ABSTRACT ………………………………………………………………….………………………………………………... 85
3.2 INTRODUCTION …………………………………………………………………………………………………………... 86
3.3 METHODS ……………………………………………………………………………………………………………………. 89
3.3.1 Nutrigenetics-D: The Nutrigenetics Database Builder ..………………………………………... 89
3.3.2 Nutrigenetics-R: The Nutrigenetics Personalized Diet Report Program .…………….…. 91
3.4 RESULTS ……………………………………….……..………………………………………………………………………. 93
3.5 DISCUSSION ………………………………….……..………………………………………………………………….… 100
3.6 REFERENCES ………………………..……………..…………………………………………………………………….. 103
APPENDIX ………………………………………………….………………………………………………………………………... 102
CURRICULUM VITAE …………………………………………………………………………..………………………………… 133

viii

LIST OF TABLES
Table 1.1: A Brief Summary of the Software that I Wrote ………………………………………………………… v
Table 1.2: Proportion of CMD Clones Containing Minimotifs, Before Primer Redesign ………..... 12
Table 1.3: Proportion of CMD Clones Containing Minimotifs, After Primer Redesign……….…….. 22
Table 2.1: The Set of Matrices Generated by Giga-D ...…………………………………………………………… 47
Table 2.2: Giga-D Error Codes and Error Sources …….………………..…………………………………………… 58
Table 2.3: Advantages and Disadvantages of Available Protein Function Identification
Techniques ……………………………………………………………………………..…………………………… 130

ix

LIST OF FIGURES
Figure 1.2.1 …..……………………………………………………………………...……………….…………………………..…... 3
Figure 1.2.2 …..……………………………………………………………………………………….…………………………..…... 4
Figure 1.2.3 ……………………………………………………………………………………….….………………………………... 5
Figure 1.2.4 ………………………………………………………………………………………….…..…..………………………... 6
Figure 1.2.5 …………………………………………………………………………………….……….……………………………... 8
Figure 1.2.6 ……………………………………………………………………………………..…….……………………………….. 9
Figure 1.2.7 ………………………………………………………..…………………………..……….……………………………. 10
Figure 1.2.8 ………………………………………….………………………………………..……….…………………………….. 11
Figure 1.2.9 ………………………………………………………….………………………..……….…………………………….. 13
Figure 1.4.1 ………………………………………………………….………………………..……….…………………………….. 21
Figure 1.4.2 ………………………………………………………….………………………..……….…………………………….. 28
Figure 1.4.3 ………………………………………………………….………………………..……….…………………………….. 29
Figure 1.4.4 ………………………………………………………….………………………..……….…………………………….. 30
Figure 1.4.5 ………………………………………………………….………………………..……….…………………………….. 30
Figure 2.2.1 ………………………………………………………….………………………..……….…………………………….. 41
Figure 2.2.2 ………………………………………………………….………………………..……….…………………………….. 42
Figure 2.2.3 ………………………………………………………….………………………..……….…………………………….. 43
Figure 2.2.4 ………………………………………………………….………………………..……….…………………………….. 45
Figure 2.2.5 ………………………………………………………….………………………..……….…………………………….. 49
Figure 2.2.6 ………………………………………………………….………………………..……….…………………………….. 51
Figure 2.4.1 ………………………………………………………….………………………..……….…………………………….. 67
Figure 2.4.2 ………………………………………………………….………………………..……….…………………………….. 68
Figure 2.4.3 ………………………………………………………….………………………..……….…………………………….. 69
Figure 2.4.4 ………………………………………………………….………………………..……….…………………………….. 70
Figure 2.4.5 ………………………………………………………….………………………..……….…………………………….. 71
Figure 2.4.6 ………………………………………………………….………………………..……….…………………………….. 72
Figure 2.4.7 ………………………………………………………….………………………..……….…………………………….. 73
x

Figure 2.4.8 ………………………………………………………….………………………..……….…………………………….. 74
Figure 2.4.9 ……………….…………………………………………………………………..……….…………………………….. 75
Figure 2.4.10 .…………….…………………………………………………………………..……….…………………………….. 75
Figure 2.4.11 …………………………………………………………………………………..……….……………………………. 76
Figure 2.4.12 …………………………………………………………………………………..……….……………..…………….. 77
Figure 3.4.1 …………………………………………………………………………………..………..…………………………….. 93
Figure 3.4.2 …………………………………………………………………………………..….…….…………………………….. 94
Figure 3.4.3 …….……………………………………………………………………………..……….…………………………….. 94
Figure 3.4.4 …….……………………………………………………………………………..……….…………………………….. 95
Figure 3.4.5 …….……………………………………………………………………………..……….…………………………….. 95
Figure 3.4.6 …….……………………………………………………………………………..……….…………………………….. 96
Figure 3.4.7 ………….………………………………………………………………………..……….…………………………….. 96
Figure 3.4.8 …….……………………………………………………………………………..……….…………………………….. 97
Figure 3.4.9 …….……………………………………………………………………………..……….…………………………….. 97
Figure 3.4.10 …..…………………………………………………………………………….……….…………………………….. 97
Figure 3.4.11 …………….……………………………………………………………………..……….………………………….. 98
Figure 3.4.12 …..………………………………………………………………………………..……….………………………….. 99
Figure 3.4.13 …..………………………………………………………………………………..……….………………………….. 99
Figure 3.4.14 …..……….………………………………………………………………………..……….……………………….. 100
Figure 3.4.15 …..………………………………………………………………………………..……….……………….……….. 100
Figure A1 …..……….……………………………………………………………………………..……….……………………….. 105
Figure A2 ……….……………………………………………………………………………………..……….………………….… 106
Figure A3 ……….…….……………………………………………………….………………..……….………………………….. 107
Figure A4 …..…………………………………………………………………………………..………..………………………….. 107
Figure A5 ……..………………………………………………………………………………..…….….………………………….. 108
Figure A6 ………..……………………………………………………………………………………….………………………….. 109
Figure A7 ……..………………………………………………………………………………...……….………………………….. 110
Figure A8 ……..………………………………………………………………………………...……….………………………….. 111

xi

Figure A9 ……..………………………………………………………………………………...……….………………………….. 111
Figure A10 …….…………..…………………………………………………………………...……….………………………….. 112
Figure A11 ….…..……………………………………………………………………………...……….………………………….. 113
Figure A12 ….…..……………………………………………………………………………………….………………………….. 114
Figure A13 ….….……………………………………………………………………………………….………………………….. 114
Figure A14 ……..………………………………………………………………………………..….….………………………….. 115
Figure A15 ….…………………………………………………………………………………..……….………………………….. 116
Figure A16 …….………………………………………………………………………………..……….………………………….. 117
Figure A17 …….……………………………………………………………………………..……….…………………………….. 118
Figure A18 ….………………………………………………………………………………..……….…………………………….. 119
Figure A19 ….………………………………………………………………………………..……….…………………………….. 120
Figure A20 …………….……………………………………………………………………..……….…………………………….. 121
Figure A21 .….………………………………………………………………………………..……….……..…………………….. 122
Figure A22 …………………………………………………………………………………..………….………………….……….. 123
Figure A23 ………………….………………………………………………………………..……….…………………………….. 124
Figure A24 …….……………………………………………………………………………..……….…………………………….. 125
Figure A25 A-B ………………………………………………………………………………………………………………..…… 126
Figure A25 C-D ………………………………………………………………………………………………………………..…… 127
Figure A25 E …………….……………………………………………………………………………………………………..…… 128
Figure A25 F ……….…………………………………………………………………………………………………………..…… 129
Figure A25 G ……….………………..………………………………………………………………………………………..…… 130

xii

LIST OF EQUATIONS
Equation 1: Calculation of Standard Deviation ……………………………………….……………………………... 62
Equation 2: Welch’s t-Test ………………..……………………..…………………………….……………………………... 62
Equation 3: Degrees of Freedom ……………………………..…………………………….……………………………... 63
Equation 4: Z-Score ……………………………..…………………..…………………………….……………………………... 63
Equation 5: Calculation of Predicted Number of Variants ………………………………………………………. 64

xiii

CHAPTER 1: THE CHIMERIC MINIMOTIF DECOY SCREEN
ABSTRACT
Detailed knowledge of protein functions is absolutely necessary for the understanding of how
proteins behave in cellular systems. However, the existing techniques for analyzing protein
functions and interactions are often flawed and inefficient. One possible way of analyzing
protein function is the analysis of protein minimotifs. These are short, contiguous amino acid
sequences with a known function. We have developed a protein function assay, the Chimeric
Minimotif Decoy (CMD) screen. Here, a chimeric protein, consisting of a red fluorescent protein
with C-terminal minimotifs, is over-expressed in a cell. The chimeric protein may act as a decoy
by competitively binding to the host cell’s proteins using the minimotifs. In our current proofof-concept model of the CMD screen, the cell is infected by a virus (though other versions of
the screen can be designed to screen many other systems of protein function, including those
not related to viral or bacterial infection). If the CMD protein competitively binds the host
proteins, there may be fewer that are available for the virus to utilize. This may lead to the
inhibition of infection by the virus. Virus and host protein functions and interactions may then
be determined through the identification of which minimotifs lead to the inhibition. The goal of
the first aim of my thesis was to optimize CMD library construction and to create software to
interpret data from the screen. Through the alteration of some DNA elements used in the
construction of a CMD protein, we were able to improve CMD plasmid construction rates by
about 40%. My Java language software correctly identifies minimotifs in the CMD plasmid
sequence in 100% of observed cases, and can correctly output graphs visualizing the average
inhibition rates of each minimotif included in an experiment.
1

1.2 INTRODUCTION
Many biologists in the field of proteomics endeavor to find how proteins function and interact
with each other within cellular systems. This is a major area of focus for the field. Proteinprotein interactions, specifically, can be analyzed through screening techniques such as yeast
two-hybrid and co-immunoprecipitation. These existing screens, however, can result in a false
discovery rate of up to 20% (Lievens et al., 2013). They are also limited in their ability to analyze
protein function. We can use reverse and forward genetic experiments to identify what genes
are involved in a candidate protein interaction, but we can’t really get at the molecular
mechanisms that drive those interactions. While function might be somewhat inferred through
interactions, most predictions of protein function must currently be made in silico. These
predictions are somewhat limited by their ability to predict function based on protein amino
acid sequences and structure, relating them to known functions and functional domains (Khan,
et al., 2014). This is further frustrated by the poor predictability of proteins which “moonlight,”
or serve multiple functions (Khan & Kihara, 2016). These additional functions are often
discovered accidentally during experimentation.
A more efficient way to predict protein function comes from looking not at the entire sequence
of the protein, but what minimotifs a protein contains. A minimotif is a short (typically less than
twelve amino acids in length), contiguous amino acid sequence that has a known function that
is conserved in at least one other protein (Rajasekaran et al., 2009). These sequences are also
known as short linear motifs, or SLiMs (Orlorin et al., 2015). A well-documented example of
minimotif is the PxxPxK minimotif that is preferentially bound by the Crk or SH3 domain (Wu et
al., 2007) (Figure 1.2.1). The inclusion of minimotifs in the prediction of the “moonlighting”
2

proteins in Arabidopsis thaliana was recently shown to lower false prediction rates (Wong,
Gering, & Irving, 2015). However, in order to improve the quality of available evidence for
protein function, in silico predictions must eventually be tested experimentally.

Figure 1.2.1: An example of a minimotif preferentially bound by SH3 (Wu et al., 2007).

1.2.1 The Chimeric Minimotif Decoy Assay Design
Our laboratory has designed a screen that experimentally uses minimotifs to analyze protein
function, the Chimeric Minimotif Decoy assay (CMD). In this screen, a CMD protein, which
contains at least one known minimotif, is expressed in a host cell. One or more of its minimotifs
may be identical to that of a host protein’s native ligand. In this case, the minimotif may
competitively bind the host protein, making it much less available for the normal ligand to
interact with, and thereby acting as a “decoy” (Figure 1.2.2). These interactions between the
CMD and host proteins may be able to help us to analyze the functions of the host proteins.
There is precedence for the use of decoys, as transcription factors often have non-functional,
high affinity DNA sites in the genome, which function as decoys (Kemme, et al., 2016). Also,
microRNAs have been demonstrated to work as decoys for transcription factors (Cui et al.,
2014). Oligonucleotide decoys have even been employed therapeutic use, blocking activity of
3

the E2F family of human transcription factors, thereby lowering organ graft rejection (Mann &
Dzau, 2000).
The CMD protein is “chimeric,” as it is an amalgam of parts drawn from very different sources.
The CMD protein consists of a red fluorescent protein on the N-terminal end and one or more
C-terminal minimotifs. This orientation was chosen because approximately 3,600 proteins in
the human proteome have a C-terminal minimotif (Sharma et al., 2016). Since a CMD protein
may have minimotifs from multiple proteins, it may be able to bind to different proteins and
therefore inhibit interactions between multiple proteins and multiple ligands (Figure 1.2.3).

Figure 1.2.2: (A) Under normal circumstances in a cell, a protein (blue circles) interacts with its
normal ligand (dark blue stars). (B) In a cell that expresses the CMD protein, the CMD protein
(pink/red/dark blue) minimotif (dark blue) competitively binds the protein, making it
unavailable for the ligand.
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Figure 1.2.3: A CMD protein with multiple minimotifs (in red and dark blue) may competitively
bind more than one host protein (in blue and dark red).

As a proof-of-concept experiment to benchmark the CMD screen, our laboratory analyzed the
CMD’s ability to inhibit infection by of a cell by the human immunodeficiency virus 1 (HIV-1).
HIV relies solely on host proteins in order to replicate, and therefore must interact with them
(Kok et al., 2009). Also, HIV-1’s genome has been thoroughly studied. These factors made it an
ideal candidate for analysis with the CMD screen. If a host cell expresses a CMD protein which
competitively binds the host proteins, thereby inhibiting HIV, it would indicate which protein
functions are vital to HIV infection.
In order to construct the CMD screen, our laboratory first selected the minimotifs to be
screened. This was done through Minimotif Miner 3.0, which is our laboratory’s minimotif
database program that currently contains more than 300,000 unique minimotif entries (Mi et
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al., 2011). For this first CMD library, only those minimotifs derived from HIV proteins were
included.
Once the minimotifs were selected, the CMD protein plasmids, or clones, had to be
constructed. The clones are constructed by randomly ligating together double stranded
minimotif DNA that includes both the minimotif sequence and a 6 base pair linker sequence.
This linker sequence functions as an adaptor so that the minimotifs will anneal to each other.
An initiator and terminator sequence are ligated to the 5’ and 3’ end of the insert, respectively.
This insert is then amplified through polymerase chain reaction (PCR), and then sub-cloned into
a vector plasmid (Figure 1.2.4). Our current vector contains the sequence of a mCherry red
fluorescent protein, to which we ligate the insert on the C-terminal side, creating the chimeric
protein.

Figure 1.2.4: (A) General schematic of the constituent CMD components, apart from the
mCherry vector, including the initiator, motif (in red and blue), and terminator oligonucleotide
duplexes. Each are comprised of a backwards and forward DNA sequence with a 6 base
overhang on both the 5’ and 3’ end to allow for ligation. (B) Assembly of the CMD clones.
Initiator, terminator, and minimotif oligonucleotide duplexes are randomly ligated together and
6

then sub-cloned into the vector plasmid, which has overhanging sequences (once digested with
SalI and BamHI restriction enzymes) complementary to the 5’ end of the initiator and the 3’ end
of the terminator.

Mammalian host cells are then transfected with the now complete clones. Each clone must be
separately transfected in its own well in a 96 well plate, in order to prevent any ambiguity in
the results. The mammalian cell strain chosen for this assay is the GHOST CD4+/CCR5+ cell line
(Morner et al., 1999). This cell line, derived from human osteosarcoma cells, expressed the CD4
and CCR5 receptor and coreceptor required for host cell infection by HIV, and stably cotransfected with a HIV (long terminal repeat) LTR driving hGFP construct. This LTR-hGFP
construct acts as a reporter for HIV infection as Tat, HIV’s viral transactivator protein, drives
transcription of the green fluorescent protein (GFP) using the LTR promoter (Morner et al.,
1999). After transfection and culturing, the cells are infected with HIV-1 pWT/BaL (Hwang et al.,
1991) (Figure 1.2.5).

7

Figure 1.2.5: Transfection and infection of the GHOST cell line with the CMD plasmid and HIV-1
WT/BaL, respectively. A) The cell is transfected with the CMD plasmid (red), using a transfection
agent such as Lipofectamine LTX. B) The CMD protein is expressed due to the CMV promoter on
the CMD plasmid, and the cell is infected with HIV. The

The relative fluorescence of each cell is then determined by fluorescence assisted cell sorting
(FACS). Cells are gated by levels of red (620/20 nm fluorescence filter) and green (530/30 nm
fluorescence filter) fluorescence, and sorted into separate populations. A cell that does not
fluoresce is neither expressing the CMD protein, nor is it infected. A cell that only fluoresces
green is infected, but is not expressing the CMD protein. A cell that fluoresces yellow (or both
red and green) both has CMD expression and is infected with HIV, but the CMD protein is not
inhibiting HIV. A cell that only fluoresces red can indicate one of a few things. Either the CMD
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protein is inhibiting infection by HIV, or whatever virions that may have initially entered the cell
failed to infect the cell or induce adequate expression of GFP, or no virions entered the cell
(Figure 1.2.6).

Figure 1.2.6: Possible results of the CMD screen. Grey (a non-fluorescent cell) indicates neither
infection nor CMD expression. Green indicates infection but not CMD expression. Red indicates
a possible positive result, where the CMD protein may be inhibiting HIV. Yellow indicates a
negative hit, where the cell is both infected with HIV and expressing the CMD protein, but the
protein has failed to inhibit infection.

Once the screen is complete, the CMD clones are sent for next-generation sequencing. The
sequences then are interpreted by the custom software that I wrote, CMD-1.

9

1.2.2 Optimizing Construction of the CMD Clone Library
Many CMD clones have been successfully produced. However, there was a limitation that
greatly lowered the efficiency of clone creation. Each of the constituent DNA oligonucleotide
duplexes of the CMD insert shares a complementary overhang, or “linker sequence.” This linker
sequence makes it possible for the oligonucleotide duplexes to anneal and ligate with the
preceding initiator or minimotif linker or the incoming minimotif linker or terminator. However,
the initiator and terminator oligonucleotide duplexes can use this linker sequence to anneal
directly to each other. They can then be amplified through PCR and then be sub-cloned into the
vector, resulting in the production of unusable clones with no minimotifs (Figure 1.2.7). This led
to an approximate production rate of clones without minimotifs of 60% (See Table 1.2).

Figure 1.2.7: The production of CMD clones without minimotifs. The initiator and terminator (I1
and T1) sequences anneal to each other via the linker sequence (‘L’), are amplified through PCR,
and then are sub-cloned into the vector. Linker sequences are purple and pink, initiator and
terminator sequences are green. Blue, orange, light green, and dark green represent the stop
codon, Myc tag, SalI 5’ overhang, and BamHI 3’ overhang, respectively.
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Figure 1.2.8: DNA gel electrophoresis image using I1 and T1, the original initiator and terminator
sequences used in construction of the CMD clones (Strong et al., unpublished). Clones “9-1,” “92,” “9-3,” “9-4,” “12-4,” “12-5,” and “12-6” each lack minimotifs. The green line indicates the
~80 bp band.
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Table 1.2: Proportion of CMD Clones Containing Minimotifs, Before Primer Redesign
Above 80
At or Below
Number
bp (Initiator 80 bp
Percent of Clones
Electrophoresis of Clones +
(Initiator +
Containing
Gel Number
in Gel
Terminator) Terminator)
Minimotifs:
#1
13
7
6
53.8%
#2
11
0
11
0.0%
#3
13
6
7
46.2%
#4
11
2
9
18.2%
#5
11
5
6
45.5%
#6
11
8
3
72.7%
#7
12
1
11
8.3%
#8
12
0
12
0.0%
#9
11
2
9
18.2%
#10
9
1
8
11.1%
#11
12
7
5
58.3%
#12
11
10
1
90.9%
#13
12
3
9
25.0%
#14
12
5
7
41.7%
#15
12
5
7
41.7%
#16
12
1
11
8.3%
#17
12
7
5
58.3%
#18
12
2
10
16.7%
#19
12
6
6
50.0%
#20
12
4
8
33.3%
#21
11
7
4
63.6%
#22
11
9
2
81.8%
#23
11
8
4
72.7%
Percent of Clones Containing Minimotifs for 23 Gels:
39.85%
Analysis of 23 PCR product DNA gel electrophoresis images of gels containing clones produced
with the original I1 initiator and T1 terminator sequences.

This problem was a major barrier for the initial portion of my first thesis aim, which was the
optimization of CMD library construction. This limitation has been ameliorated, to a certain
extent, by altering the initiator and terminator sequences. We added a BstXI restriction
enzyme (New England Biosciences) recognition site to the initiator and terminator sequences.
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The site is split between the initiator and terminator linker sequences. By digesting PCR
amplified clone inserts made with these adapted sequences, any insert having only the initiator
and terminator sequences are far less likely to yield complete clones. The two fragments
created are less likely to be sub-cloned into the vector and create circular plasmids (Figure
1.2.9).

Figure 1.2.9: The BstXI restriction site solution. Linker sequences are purple and pink, initiator
and terminator sequences are green. Blue, orange, light green, and dark green represent the
stop codon, Myc tag, SalI 5’ overhang, and BamHI 3’ overhang, respectively. (A) The sequence
of the BstXI restriction site (New England BioScience). (B) BstXI digestion of the initiatorterminator amplicon. (C) BstXI digestion with detailed sequences.

1.2.3 The CMD Sequence Analysis Software Overview
To accurately interpret the CMD clone sequences in order to determine their minimotif
compositions, I wrote JavaTM language (Gosling, copyright 1997-2017) software, CMD-1,that
both interprets the sequences of each clone and de-convolves the clones to give a total average
fluorescence score for each minimotif. This total average fluorescence score indicates whether
a minimotif inhibits HIV infection. The fluorescence score for a clone is calculated as n percent
of all red fluorescing cells that are also green. In other words, it is a measure of cells that
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express a given CMD protein but that are also infected with HIV, as a percentage of all of the
cells expressing that CMD protein. Therefore, a cell with a low fluorescence score would
indicate a stronger inhibitor (since there are less cells that are infected), and a high
fluorescence score would likewise indicate a weak inhibitor.
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1.3 METHODS
1.3.1 CMD Clone Construction
CMD Linker Sequence Creation
CMD linker sequences were formed by phosphorylating and annealing corresponding forward
(5’ to 3’ sense) and reverse (3’ to 5’ antisense) primer sequences (each composed of the
nucleotide sequence for a given peptide minimotif, plus the linker sequence). Forward and
reverse primers for each minimotif were separately incubated (final concentration of 6 µM of
each) with 5 µL of 10x concentration T4 Polynucleotide Kinase Reaction Buffer (New England
BioLabs (NEB)), ATP (200 µM final concentration) (NEB), 0.3 µL of T4 polynucleotide kinase, and
autoclaved Milli-Q® water (Milli-Q® Integral Water Purification System for Ultrapure Water,
Sigma-Aldrich) per sample in a thermal cycler (Mastercycler gradient Thermal Cycler,
Eppendorf) at 37°C for 4 hours. The T4 polynucleotide kinase was heat inactivated by
incubating primers at 65°C for 20 minutes in the thermal cycler. The corresponding forward and
reverse primers were then combined and annealed in a Techne TC-500 Gradient PCR Thermal
Cycler by heating primers to 95°C and then decreasing the temperature by 0.1°C per second
until a final temperature of 25°C was reached. The samples were then held at 4°C, and then
stored at -20°C. This protocol was also repeated with initiator and terminator linker sequences.
Annealing and Ligating of CMD Plasmid Inserts
CMD sequence plasmid inserts were then formed by annealing and ligating together
oligonucleotide duplexes in a single pool. Oligonucleotide duplexes were heated to 37°C. 2 µL
of the initiator linker sequence was aliquoted into a 1.5 mL microcentrifuge tube (Fisher
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Scientific) with 2 µL of each minimotif oligonucleotide duplexes mixture. 2 µL of the terminator/
oligonucleotide duplexes pool was then aliquoted to the tube, which was then incubated at
55°C for 5 minutes in a pre-heated heating block (Reacti-Therm III Heating Module, Pierce). 10
µL of this oligonucleotide duplexes mixture was aliquoted to a separate 1.5 mL microcentrifuge
tube, along with 10 µL of 2x concentration Quick Ligase Buffer (NEB), initiator sequence primer
(1 µL of 100 mM, to a final concentration of 4.5 mM), and 1 µL of Quick Ligase (NEB). This
mixture was incubated at 22°C for 30 minutes.
Affinity Chromatography Separation of CMD Plasmid Inserts
CMD inserts were then separated by relative size through the use of affinity chromatography
(illustraTM NickTM Columns SephadexTM G-50 DNA grade, GE Healthcare Life Sciences). The
NickTM column was first washed with 4 mL of TE buffer. 20 µL of the ligation reaction mixture
was then added to the column. To elute the inserts from the column, 1 mL of TE buffer was
slowly added. Fractions were collected in a 96 well plate until 32 fractions had been collected.
Further fractions were excluded from collection to increase the likelihood of collecting only
those inserts containing more than one minimotif, which correspond to larger DNA fragments.
PCR Amplification of CMD Plasmid Inserts
CMD inserts were then amplified through polymerase chain reaction (PCR). 13 µL of eluted
fraction (from the first 4 fractions of the nickel affinity chromatography) was aliquoted to a 1.5
mL microcentrifuge tube, along with 0.5 µL of the forward primer for the initiator sequence, 0.5
µL of the reverse primer for the terminator sequence, 2.5 µL of 10x concentration ThermoPol®
Reaction Buffer (NEB), mixed dNTPs (100 µM final concentration) (NEB), and 0.125 µL of Taq
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DNA polymerase (NEB). The mixture was heated to 94°C for 5 minutes in a thermal cycler, after
which the temperature was lowered to 55°C for 30 seconds, and raised to 68°C for 1 minute.
This was repeated for another 39 cycles for a final 40 cycles in total. During the final cycle the
mixture was held at 68°C for 5 additional minutes. The thermal cycler temperature was then
lowered to 4°C and held there in preparation for storage in a -20°C freezer.
DNA Agarose Gel Purification of CMD Plasmid Inserts
The PCR products were isolated via agarose gel purification. 25 µL of each sample was
separately mixed with 5 µL of 6x concentration blue loading dye (NEB) and loaded into a 14 well
2.5% low melting agarose gel (with 3 µL of ethidium bromide (Sigma-Aldrich)). 12 µL of 100 bp
DNA ladder with blue loading dye (NEB) was also loaded. The gel was run at 150 V for 45
minutes to an hour. DNA inserts were manually visualized with a UV lamp and bands larger than
80 bp (thereby lowering the chance of generation of clones without a single minimotif, as the
size of the initiator and terminator alone is 67 bp) were manually excised and then purified
according to the Promega™ Wizard™ SV Gel and PCR Cleanup System protocol.
Triple Digestion with Restriction Enzymes of CMD Plasmid Inserts
In order to generate 5’ and 3’ overhangs on the CMD inserts and prevent the inclusion of inserts
without minimotifs, amplified inserts were digested with both the appropriate restriction
enzymes for annealing and ligation with the plasmid and BSTXI, which would cleave only those
inserts where the initiator and terminator sequences were directly ligated to each other. 78 µL
of gel purified PCR products were aliquoted into a 1.5 mL microcentrifuge tube with 10 µL
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NEBuffer™ 3.1 (NEB), 0.5 µL SalI restriction enzyme, 0.5 µL BamHI restriction enzyme (NEB), and
0.5 µL restriction enzyme (NEB). This mixture was then incubated at 37°C for 2 hours.
Phenol-Chloroform Extraction of CMD Plasmid Inserts
Inserts were purified through phenol-chloroform extraction. 100 µL of autoclaved Milli-Q®
water was added to the digested samples, followed by a volume of phenol-chloroform equal to
that of the total amount of liquid in the microcentrifuge tube. The mixture was vortexed for 15
seconds, and then centrifuged for 2 minutes at 13,200 rpm (10,714 g) at room temperature.
The resulting aqueous layer was aliquoted into a clean 1.5 mL microcentrifuge tube. An equal
volume of phenol-chloroform was added, and the tube was vortexed for 15 seconds (in a
Vortex Genie Mixer, Scientific Products) and then centrifuged for 2 minutes at 13,200 rpm
(10,714 g) and room temperature (in a Centrifuge 5415 R centrifuge, Eppendorf). The aqueous
layer of this second tube was then aliquoted to a clean 1.5 microcentrifuge tube with 1 µL
glycogen, 15 µL 3M sodium acetate, and 400 µL 95% ethanol. The DNA was allowed to
precipitate by incubating at -20°C overnight. Samples were then centrifuged for 30 minutes at
13,200 rpm (10,714 g) and -4°C. The supernatant was removed and the remaining pellet was
washed with pre-chilled 75% ethanol, centrifuged for 5 minutes at 13,000 rpm (10,714 g) and 4°C. The supernatant was removed and the pellet was allowed to dry for 10 minutes and 6 µL
autoclaved Milli-Q® water was added.
Preparation of the pmCherry-C1 Plasmid Vector
The pmCherry-C1 plasmid (Clontech) was digested with the appropriate digestion enzymes in
preparation for ligation with the CMD inserts. 32 µL of mCherry plasmid (157 ng/ µL) was
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aliquoted into a 1.5 mL microcentrifuge tube with 38 µL autoclaved Milli-Q® water, 9 µL
NEBuffer™ 3.1, 1 µL SalI restriction enzyme, and 1 µL BamHI restriction enzyme. This mixture
was then incubated at 37°C for 5 hours. 10 µL 10x concentration Antarctic phosphatase buffer
(New England BioLabs) and 1 µL Antarctic phosphatase (New England BioLabs) was added and
plasmid sample was incubated for an additional 20 minutes, after which the now digested
vector was purified through phenol-chloroform extraction, as with the CMD inserts.
Ligation of the CMD Inserts to the pmCherry-C1 Plasmid Vector
In order to ligate the CMD inserts to the vector, 3 µL of CMD insert (200 ng/µL) and 1 µL (200
ng/µL) of digested and purified vector was aliquoted to a 1.5 mL microcentrifuge tube with 5 µL
of 2x concentration Quick Ligase Buffer (NEB), 0.5 µL of Quick Ligase, and 0.5 µL of autoclaved
Milli-Q® water. The ligation reaction was allowed to proceed at room temperature for 30
minutes.
Transformation of the CMD Plasmids into E. coli DH5α Competent Cells
E. coli DH5α competent cells were thawed on ice for 15 minutes. 90 µL of competent cells were
then aliquotd to pre-chilled Falcon tubes. 10 µL of (200 ng/µL) DNA was then added to each
sample. The samples were then incubated on ice for 30 minutes, after which 300 µL of
autoclaved LB broth was added. The cultures then were incubated at 37°C for 1 hour. After this,
250 µL of each sample was added to a dry LB/Kanamycin agar plate (0.1% Kanamycin) (the
mCherry plasmid has a Kanamycin resistance gene for selection). The plates were spread, and
then incubated for 16 hours at 37°C, and then stored at -20°C.
E. coli Colony PCR
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Colony PCR was performed by selecting a single CMD plasmid-transformed E. coli DH5α colony
for each sample. This colony was then added to an aliquoted 10 µL of colony PCR reaction
mixture. This mixture consists of CMD initiator forward primer (final concentration of 1 µM),
CMD terminator forward primer (1 µM final concentration), dNTP mixture (100 µM final
concentration), 50 µL 10x concentration Taq polymerase buffer (NEB), 5 µL Taq polymerase
(NEB), and 420 µL of autoclaved Milli-Q® water. The mixture was heated to 94°C for 5 minutes
in a thermal cycler, after which the temperature was lowered to 55°C for 30 seconds, and
raised to 68°C for 1 minute. This was repeated for another 39 cycles for a final 40 cycles in total.
During the final cycle the mixture was held at 68°C for 5 additional minutes. The thermal cycler
temperature was then lowered to 4°C and held there in preparation for storage in a -20°C
freezer.
Visualization Through DNA Gel Electrophoresis
The PCR products were visualized via DNA gel electrophoresis imaging. 25 µL of each sample
was separately mixed with 5 µL of 6x concentration blue loading dye (NEB) and loaded into a 14
well 2.5% agarose gel (with 6 µL of ethidium bromide (Sigma-Aldrich)). 12 µL of 100 bp DNA
ladder with blue loading dye (NEB) was also loaded. The gel was run at 150 V for 45 minutes to
an hour. DNA inserts were visualized using UV light. Images were taken by exposing each gel for
between 3 and 8 seconds.
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1.4 RESULTS
1.4.1 Library Construction Optimization
The introduction of the BSTXI restriction site to the CMD initiator and terminator sequences
resulted in a large increase in the number of CMD clones containing minimotifs. This was
determined by visual analysis of DNA gel electrophoresis images of amplified products from
both before and after the new sequences were introduced into the construction of the CMD
clone library (Figure 1.2.8, Figure 1.4.1, Table 1, Table 2). While clones lacking minimotifs were
still produced, the frequency at which they occurred was greatly reduced, from 60% (Table 1.2)
to 17.8% (Table 1.3).

Figure 1.4.1: DNA gel electrophoresis image using IBSTXI initiator and TBSTXI terminator sequences
(Dr. Ronald Benjamin Babu, unpublished). Clones “37,” “38,” and “39” contain no minimotifs.
The green line indicates the ~80 bp band.
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Table 1.3: Proportion of CMD Clones Containing Minimotifs, After Primer Redesign
Number
Above 80 bp At or Below 80 Percent of Clones
Electrophoresis of Clones (Initiator +
bp (Initiator +
Containing
Gel Number
in Gel
Terminator)
Terminator)
Minimotifs:
#1
26
20
6
76.9%
#2
12
10
2
83.3%
#3
12
11
1
91.7%
#4
24
21
3
87.5%
#5
22
19
3
86.4%
#6
24
20
4
83.3%
#7
11
4
7
36.4%
#8
22
21
1
95.5%
#9
11
10
1
90.9%
#10
26
20
6
76.9%
#11
8
8
0
100.0%
Percent of Clones Containing Minimotifs for 11 Gels:
82.8%
An analysis of 11 PCR product DNA gel electrophoresis images of gels containing clones
produced with the IBSTXI initiator and TBSTXI terminator sequences.

1.4.2 The CMD Sequence Analysis Software – CMD-1 & CMD-2
The first module of the CMD Software, CMD-1, which can be used to analyze the sequencing
data from the Chimeric Minimotif Decoy screen. This module can be selected through a
command line argument provided in addition to locations of required files (software
configuration file, CMD clone sequencing data file, and CMD clone FACS score file). Once these
command line arguments are provided with the command to execute, the software reads the
required constants, protein nucleotide sequences, and minimotif and
initiator/terminator/linker (ITL) sequence library file locations from the configuration file.
The program then reads the minimotif and ITL library files. The minimotif library file is a tab
separated values text file (TSV) where each line contains the name and orientation, either
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“forward” or “reverse,” of a minimotif in the CMD sequence library and the matching
nucleotide sequence. The ITL library file is a TSV containing the name and sequence of the
initiator, terminator, and linker sequences that are shared by every clone in the library. These
lines are then parsed into arrays of objects (instances of developer designed custom Java
classes), “MinimotifLibrary” and “ITLLibrary” respectively. The former class contains fields for
the name and sequence, in addition to fields for use later on in the program that are required
for statistical analysis. The latter class contains name and sequence fields, along with Boolean
flags identifying the sequence as an initiator, terminator, or linker.
The input sequencing data (a FASTQ file) is then processed, line by line, and reads are parsed
into an array of “CMDRead” objects, which contain fields for the read name (identified in the
sequencing file with the line-starting “@” or “>” character, containing the name of the CMD
clone), the nucleotide sequence of the read, and the sequence’s associated string of Phred
quality score characters. “CMDRead” also contains many other fields which will be filled by the
software later.
The CMD clone FACS score file is read into the program. This is yet another tab separated text
file containing the names of clones and their FACS green fluorescence scores. These scores
correspond to the proportion (in percent) of GFP positive cells out of the mCherry positive
population, selected through gating in FACS. Lines from this file are parsed into an array of
“CMDFluor” objects, which contain fields for the clone name and score.
The program then performs a regular expression search on each read sequence, comparing it to
each minimotif sequence in turn and testing if the read contains the minimotif. Information for
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matching minimotif sequences is copied from the “MinimotifLibrary” object to “FoundMotif,” a
child class of “CMDRead.” This object, which contains fields for the start and end positions of
the matching minimotif sequence within the read, is then saved to a list in a dedicated field
within the “CMDRead” object. Once all of the minimotifs have been iterated through and
compared to a given read, the program checks whether any minimotifs were found at all. If not,
then a specific error code indicating this is added to a list for that read.
This process of searching for sequences within the read is repeated for the initiator and
terminator sequences and (optionally) the linker sequence. If an initiator or terminator
sequence for a read cannot be found, an error code is added to the list. Whether the linker
sequence is required depends on a binary setting in the configuration file, as some versions of
the minimotif library file contain sequences that already contain linker sequences.
The program then sorts the initiator, terminator, and all of the found minimotifs. If there is an
overlap between any of these elements, an error code is added to the list. Another error code
will be added in the event that a minimotif occurs in the read outside of the space between
initiator and terminator sequences. Unidentified sequences located between known elements
in the sequence of interest, starting from the initiator (if one can be found), are saved in
another child class of “CMDRead,” “CMDGap.” This class includes fields for the gap sequence,
and the starting and ending indices for where it is located within the read sequence. Any time
an unidentified gap sequence is found, a “CMDGap” object is instantiated and added to a list of
“CMDGap” objects within the “CMDRead” object.
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An average Phred score, which indicates the level of quality of the read sequence as
determined by the base calling function of the DNA sequencing equipment, is calculated from
the sequence of interest for Phred quality characters corresponding from the read sequence
starting at the beginning of the initiator and the end of the terminator sequence in the case of
forward sequence reads (Ewing & Green, 1998). Each glyph is an ASCII character with a unique
𝑄

Q score, and is used to calculate the error probability, P, in the equation 𝑃 = 10−10 . In the
case of reverse sequence reads, the Phred quality characters used in calculation correspond to
the read sequence starting from the terminator sequence start index and the initiator sequence
end index. If either the initiator or terminator sequences are not found, the entire beginning or
ending of the Phred sequence is included, corresponding to the missing element. Each glyph in
the Phred character string is then converted to its ASCII integer value, which is in turn used to
find the Q score, a value between 0 and 93, corresponding to a probability (P) of a wrong base
call between 1.00 and 0.0000000005 (Cock et al., 2009). All Phred scores in the sequence of
interest are summed and divided by the number of glyphs to find the average Phred score. Any
read with an average Phred score which falls below the lowest threshold quality score (set by
the user in the configuration file) is assigned an error code. The default quality threshold is 30,
or an average wrong base probability of 0.0010000000.
The names of the clones in the “CMDFluor” array are then compared to each read name in the
“CMDRead” array. The green fluorescence score is copied to a corresponding field in the
matching read object.
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Information on each read, including the proper order of initiator (if present), minimotifs,
unidentified gap sequences, and terminator, along with the average Phred score and green
fluorescence score, are written to a text file for analysis by the user.
In order to calculate the mean green fluorescence score for each minimotif, the program once
again iterates over the “MinimotifLibrary” array, and searches through the “CMDRead” array
for reads containing matching minimotifs in their “FoundMotif” lists. Read objects that contain
a given minimotif sequence are added to a list of reads within the “MinimotifLibrary” object.
Once all reads have been matched to all possible “CMDRead” objects, quality checks are
performed in preparation of statistical analysis. Reads with average Phred scores lower than
the allowed threshold are excluded from further analysis. Reads having neither initiator nor
terminator sequence are likewise excluded. Duplicate reads are matched by name, their Phred
scores are averaged, and they are henceforth counted as a single read.
Mean green fluorescence (x̅) is calculated for each minimotif by calculating the sum of the
green fluorescence scores for all valid reads, and then dividing by n, the number of valid reads
included in the sum). This is then used to calculate minimotif’s standard deviation (σ) and
variance (σ²). The program then searches through the “CMDFluor” array for objects containing
the name field values “PositiveControl” and “NegativeControl,” correlating, of course, to the
positive and negative control clones in the experiment. The positive control green fluorescence
score is used to find the z-score and corresponding p-value for each minimotif.
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Data and statistical values for each minimotif (name, mean green fluorescence score, number
of valid reads, standard deviation, variance, Z-score, and P-value) are output to a tab separated
text file.
Mean green fluorescence for each minimotif is then plotted on a graph using the sub-module,
CMD-2, which itself uses the JFreeChart Java graph visualization library (Gilbert, 2015). The bars
along the x-axis of this graph correspond to each minimotif, along with a separate bar for the
positive and negative controls on each graph. The number of minimotifs to include in each
graph is set by the user in the configuration file. The y-axis of the graph represents the mean
green fluorescence (as a percentage, in intervals of 10%). The color of each bar also represents
the mean green fluorescence, as a gradient from red (0% mean green fluorescence) to green
(100% mean green fluorescence). Each graph is output as an image file and other statistics (n
number of valid reads, standard deviation, variance, z-score, and p-value) are added manually,
as per the information saved in the tab separated text file.
1.4.3 CMD Clone Sequence Analysis Program (CMD-1 & CMD-2) Validation
Using the CMD minimotif library TSV file, initiator terminator and linker sequence TSV file, and
CMD clone next generation sequencing file as inputs (Figure 1.4.2), CMD-1 accurately
interpreted the minimotif composition of CMD clones for all tested sequences. The CMD FASTQ
file used to test this consists of 96 clone sequences. These sequences were manually verified
twice by comparing the sequences to the minimotif library file. During the first manual analysis,
the researchers made errors in identifying the minimotifs of 15 sequences. Further analysis was
done to verify the actual composition of the sequences. 17 of these clones contained no

27

minimotifs, 4 contained either no initiator or terminator, and 5 sequences could not be
analyzed do to an error in either the production of the sequencing sample or in the process of
next generation sequencing. The program was correctly able to interpret sequences in each of
these cases (Figure 1.4.3).

Figure 1.4.2: The input files for the CMD Clone Sequence Analysis Program. (A) An example
portion of the CMD minimotif library TSV file. (B) The CMD initiator, terminator, and linker
sequence TSV file. (C) An example portion of the clone FASTQ file.
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Figure 1.4.3: Example portions of the sequence analysis file produced by the CMD Clone
Sequence Analysis Program. (A) The analysis file contains sections for both clones that contain
minimotifs, and for those that lack minimotifs, an initiator sequence, a terminator sequence, or
a sequence that is otherwise unreadable. (B) An example of a sequence where manual
interpretation by a researcher failed to accurately identify a minimotif, “M300,” but where the
sequence analysis program did not.

The correct generation of de-convolved minimotif fluorescence score graphs was verified using
the previously analyzed FASTQ file, along with additional simulated sequences constructed
manually and a simulated fluorescence score file (Figure 1.4.4). CMD-2, the graphing submodule of CMD-1, calculated an average fluorescence score for each minimotif found in the
sequences and produced an additional metrics file for later analysis. The graphs produced by
the program correctly displayed the average fluorescence score for each minimotif (Figure
1.4.5).
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Figure 1.4.4: The clone fluorescence score file. Values represent the percent amount of GFP
positive (green fluorescing) cells in a sample group composed entirely of mCherry positive (red
fluorescing) cells. All values here are simulated and columns have been aligned for better
visualization.

Figure 1.4.5: A bar graph, produced by CMD-2, showing the average amount of green
fluorescent cells for each minimotif. All values here are simulated.
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1.5 DISCUSSION
The addition of the BstXI restriction site greatly increased the efficiency of CMD clone
production, by an approximate amount of 40%. While clones with no minimotif are still created,
the amount of usable clones has made the CMD library construction process much less costly,
both in terms of time and resources.
The CMD-1 correctly identified minimotifs and other elements correctly in all 96 sequences
within the test file, even correctly analyzing reads where human interpretation had generated
errors.
While the Chimeric Minimotif Decoy assay does show promise as a protein function analysis
tool, it does have some distinct limitations. Each clone must be tested separately in order to get
clear results as to which minimotifs yield which results. This is greatly limiting in terms of the
amount of clones that can be screened at a given time. Also, the ambiguous result of a red
fluorescent cell could lead to a higher false discovery rate, where clones could be falsely
identified as positive inhibitors, but in actuality are simply cells that may not have ever
contained any virions. While this event could be predicted statistically, by calculating the
likelihood of infection from the titer of virus used, it still may cause some error in results. Also,
any inhibitions of the HIV-1 viral life cycle that exist downstream of the Tat transcription step
will be missed, leading to Type II errors. Lastly, the construction of the clones is limited to the
inclusion of only those minimotifs which are already known and excluding any novel, and
potentially interesting minimotifs that are not in the Minimotif Miner 3.0 database. These
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limitations have led to the creation of the GigaAssay, which will be discussed in Chapter 2 of
this thesis.
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CHAPTER 2: THE GIGAASSAY
2.1 ABSTRACT
The majority of available techniques that can be used to test protein functions carry
considerable limitations. The biggest limitation of current protein function screens, however, is
that they are often labor intensive, low-throughput, and not generalizable in their design. Our
laboratory has designed a protein function screen, the GigaAssay, as a much faster, more
efficient alternative. Through this screen, one application is to comprehensively screen a
majority of all possible variants of a protein, and their effects on protein function, in a single
experiment. In the first version of this screen, the GigaAssay Driver Mutagenesis Screen, we
have constructed a library of donor plasmids with GigaAssay cassettes. The cassettes consist of
a randomly mutagenized driver protein gene and a gene for a reporter. Both genes belonging to
a single cassette in a plasmid share a unique barcode sequence. The cassette is integrated into
a mammalian host cell using the CRISPR/Cas9 system and homologous recombination. The
driver protein is expressed in the cell and drives the transcription of the reporter protein. All
cassette containing cells are cultured together in a single pool. The driver and reporter
transcripts for the entire culture are then determined through RNA-Seq. The resulting nextgeneration sequencing reads of each transcript type can each be related to their unique
cassette, through their barcode sequence. The ratio of reporter to driver reads can then be
used to identify the relative transcriptional strength of each driver variant. The second version
of the GigaAssay that we have designed, the GigaAssay MD Screen, uses much of the same
experimental design of the original CMD screen. However, through the use of the GigaAssay
cassette, we can screen very large libraries of CMD proteins and their ability to inhibit HIV
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infection in a single experiment. The second and third aims of my thesis were to create a Java
language software suite to interpret the large amounts of data coming from both versions of
the GigaAssay, and visualize the results. My software correctly analyzes an estimated 98.6% of
reads from each screen and visualizes the data for both.
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2.1 INTRODUCTION
There are many screening techniques currently available in the field of molecular biology that
allow for the direct analysis of protein-protein interactions and other protein-ligand
interactions. However, not many have been developed to analyze protein function in the
context of a mammalian cell. Interactions between proteins and other molecules and, on a
narrower scale, interactions between domains of proteins, can be inferred through assays like
yeast two-hybrid screens, co-immunoprecipitation, or more recent technologies such as PPiSeq
(Schlecht et al., 2017). All of these techniques have some significant limitations such as the
creation of Type I and Type II errors. These could be due to the lack of detection of transient
interactions. They might also be unable to detect trans-membrane protein interactions, as in
the case of yeast two-hybrid screens. They might detect interactions in cellular compartments
to which proteins of interest are not native (Brückner et al., 2009), leading to the creation of
Type I errors (false positives). Co-immunoprecipitation, while a well-validated and reliable
technique, can often be very difficult to optimize, as it is very labor intensive and antibodies
must be highly specific to the proteins of interest (Miernyk et al., 2009). PPiSeq relies on
pairwise mating between yeast strains and subsequent Cre-Lox recombinations, making it a
relatively low throughput screen (Schlecht et al., 2017). Protein functions and interactions with
other molecules can also be computationally predicted using tools such as MNet, a protein
function network generator (Yu et al., 2015), or Minimotif Miner 3.0, a database for discovery
of minimotifs based on annotations of existing literature (Mi et al., 2011). Eventually though, in
silico predictive models must be validated through in vivo or in vitro experimentation. None of
these screens can directly determine protein functions, nor can they directly examine functions
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of individual domains within proteins or their protein-molecule interactions (whether they be
protein-protein, protein-nucleic acid, or any other interaction between a protein and a
molecule).
This lack of efficient and accurate protein function screens can have a large impact on the
discovery rate of efficient drugs, which are often designed to disrupt the most critical functions
of target proteins. For example, a 2006 review (Cheng et al) on drug targets found through the
prediction of intrinsically disordered protein functions noted that though intrinsically
disordered proteins could make adequate candidates for drug targets, there was little existing
experimental support for the bioinformatic predictions.
Determining exact protein functions is also critical for the treatment of viral infections, such as
the human immunodeficiency virus (HIV). Many HIV proteins are predicted to be very good
targets for drugs, but one key protein in particular, Tat (the viral transactivator protein), makes
for an especially attractive point of weakness in the HIV replication cycle to target. This is due to
its central role in the transcription of the HIV genome during the process of replication (Li, et
al., 2012). Tat, a powerful transcription factor which is typically around 90 amino acids long,
binds indirectly to the TAR region of the nascent mRNA transcribed downstream of the HIV-1
long terminal repeat (LTR), its promoter. However, the sequence of Tat varies wildly from strain
to strain, and LTR-lacZ transactivation assays have demonstrated that Tat can retain almost all
of its normal activity while up to 38% of its sequence has been mutated (Opi et al., 2002).
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2.2.1 The GigaAssay Driver Mutagenesis Screen
Our laboratory has designed the GigaAssay, a protein function assay originally intended to be a
higher throughput version of the CMD screen. We did this with the intention of relieving the
current limitations of protein function analysis. Currently, there are two versions of the
GigaAssay, which is a highly versatile tool which can be adapted to test many different proteins
and their functions.
The GigaAssay is a high throughput screen which can be used to directly assess the activity
levels of different variants of a given protein, and thereby infer impact of different domains of a
protein on its function. These activity levels are determined by the individual relationships
between numbers of driver and reporter transcripts (determined by RNA-Seq) in numerous
small cell populations. This gives us the ability to comprehensively screen the very large
numbers of protein variants. (Note: some information regarding the GigaAssay has been
withheld or redacted in this work, in compliance with the author’s non-disclosure agreement
(NDA)). The GigaAssay is constructed by building GigaAssay DNA cassettes (Figure 2.2.1) and
subcloning them into a donor vector. The cassettes are then integrated into a mammalian host
cell through the use of the CRISPR/Cas9 system (Ma et al., 2014). The site of integration is the
adeno-associated virus integration site 1 (AAVS1). AAVS1 is a well-documented safe harbor site
within an open region of chromatin, where the activity of the GigaAssay cassette is less likely to
be inhibited, and where its integration is unlikely to disrupt the sequences of the mammalian
genome (Luo et al., 2014).
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Figure 2.2.1: A generalized diagram of the GigaAssay system. The driver protein (blue) is
transcribed and translated, and in turn drives the transcription of the reporter protein.

The GigaAssay cassette consists of two genes, a driver and reporter gene, and their respective
promoters. Currently, the cytomegalovirus (CMV) promoter is used for the driver, since genes
under the control of this promoter are constitutively expressed. The promoter is determined
based on the end goal of the given version of the GigaAssay.
For our first validation assay (Figure 2.2.2), we have chosen a driver mutagenesis screen, where
the driver protein, Tat, is randomly mutagenized to produce multiple tat variants through error
prone polymerase chain reaction (EP-PCR). Therefore, we have chosen the HIV-1 LTR as the
reporter promoter, and green fluorescent protein (GFP) as the reporter.
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Figure 2.2.2: The Tat driver protein mutagenesis version of the GigaAssay, which we have used
to validate the system. The driver protein, Tat (in purple), is expressed and drives the
transcription of the reporter GFP (in green).

The key component of the GigaAssay cassette that makes the assay high throughput is the 32
base pair barcode sequence that is shared by both the driver and reporter mRNA. This barcode
is unique to each individual cassette. The mammalian cells replicate many times over within a
cell culture, and therefore the cassette is no longer technically unique. However, each small cell
population, whose lineage can be traced to a cell with a unique cassette, carries that unique
barcode. It is through this that the specific driver sequence and the numbers of driver and
reporter transcripts of that small cell population can be related to each other unambiguously.
Therefore, we can screen upwards of106 variants in a single cell culture (depending on the cell

42

culturing process). This relieves a large limitation of traditional screening methods, where single
protein variants in a driver/reporter screen must be cultured separately in order to accurately
determine effects (Figure 2.2.3). This difference greatly increases the amount of variants that
can be screened in a single experiment. Based on our mutation rate (see EP-PCR method). We
expect to screen all single mutation driver variants (1,634 variants) and roughly 1,319,455
double mutation driver variants (see Equation 5). The advantages and disadvantages of the
GigaAssay, relative to other techniques, are shown in Table 2.3.

Figure 2.2.3: A comparison of traditional screening methods and that of the GigaAssay. Using
normal methods (left), each driver variant must be cultured separately in a 96 well plate in
order to unambiguously determine the effects of the driver protein on the reporter. Using the
GigaAssay (right), however, many variants may be pooled together in a single culture and still
be accurately analyzed.

RNA-Seq (Wang et al., 2009) is performed after a long period of incubation. In this process,
mRNA transcripts are incubated with reverse transcriptase to produce cDNA. Specific primers
are used to obtain specific cDNA covering the driver and reporter sequences. This cDNA is then
sent for next-generation sequencing at the NIPM Sequencing Core.
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Once sequencing data is received, the relative numbers of driver and reporter reads can be
calculated. The ratio of reporter to driver reads for a single cell population, related by the
unique barcode, can indicate the driver variant’s level of activity. A higher reporter to driver
ratio indicates that the variant has good activity as a transcription factor, since smaller number
of driver transcripts has led to the transcription of a larger number of reporter transcripts. A
low ratio would indicate the opposite, that the driver is a weak transcription factor.
2.2.2 The GigaAssay Version of the Minimotif Decoy Screen (MD)
We have also designed a version of the GigaAssay for use with the CMD screen (Figure 2.2.4).
Unlike in the original screen, however, the GigaAssay MD screen does not require the
construction of individual clones with known minimotifs. Here, the driver protein ends on the Cterminal side with a random amino acid hexamer sequence. In this version of the GigaAssay,
the cells are transfected with the donor plasmid and CRISPR/Cas9 system, and then infected
with HIV-1 WT/BaL, in order to test whether the hexamer sequence would inhibit infection, in
accordance with the previous design of the CMD screen. LTR-GFP again serves as the reporter,
as GFP fluorescence indicates that the cell is infected with HIV. The MD hexamer’s ability to
inhibit HIV infection can be inferred by the reporter to driver read ratio, as a good inhibitor
would lead to a proportionally lower number of GFP transcripts.
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Figure 2.2.4: The CMD version of the GigaAssay. (A) The CMD hexamer on the C-terminal side of
the driver protein may or may not inhibit HIV infection. When HIV is not inhibited by the CMD
hexamer, Tat drives the transcription of GFP, which acts as a reporter for HIV infection. (B) The
key differences between the original CMD protein and that of the GigaAssay. While the original
CMD protein contained known minimotif, the GigaAssay version contains a sequence of 6
random amino acids.

2.2.3 GigaAssay Software Overview
Custom software had to be written for both versions of the GigaAssay in order to analyze the
very large amount of data it produced. I wrote JavaTM language (Gosling, copyright 1997-2017)
software, consisting of a module for interpretation of data coming from each version of the
screen. In order to validate the software, I also wrote a separate program to generate
simulated sequences.
The synthetic read generation program, Giga-G, produces simulated sequences output in the
form of a FASTQ file, which contains both the DNA sequences and a related quality score glyph,
or alphanumeric or symbolic character, for each base in each sequence. The program creates
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reads with “mutated” driver sequences for the driver mutagenesis screen, and driver proteins
with random 18 base sequences for the hexamers in the CMD screen.
The sequence analysis program, Giga-D, imports the FASTQ file and interprets the composition
of each sequence, including the driver, reporter, and barcode sequences. It also calculates an
average Phred quality score for each read. The Phred score is the measure of quality for a given
base which correlates to the next generation sequencing software’s certainty of whether the
base has been correctly identified. Each glyph is an ASCII character with a unique Q score, and is
𝑄

used to calculate the error probability, P, in the equation 𝑃 = 10−10 . The program sorts all
sequences by barcode and then sorts those barcode populations into categories based on
various characteristics of their driver variants. These barcode super-populations are then finally
sorted into arrays based on their amino acid sequence and statistics are calculated for each
population in the array.
In order to easily visualize the statistical differences between populations, the values for each
category are represented on heatmaps. First, these statistics are used to create statistical value
matrices for each category of the variant. Each matrix represents one of 13 different statistical
values, such as the read ratio, or the total number of barcodes within a population (Table 2.1).
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Table 2.1: The Set of Matrices Generated by Giga-D
Matrix #

Matrix Type

1 Average RDRR
Average Number of Driver of Driver and
2 Reporter Reads per Barcode
3 Average Number of Driver Reads per Barcode
Average Number of Reporter Reads per
4 Barcode
5 Average Number of "Bad Reads" per Barcode
6 Total Number of Unique Barcodes
Total Number of Driver and Reporter Reads for
7 All Barcodes in Population
Total Number of Driver Reads for All Barcodes
8 in Population
Total Number of Reporter Reads for All
9 Barcodes in Population
Total Number of "Bad Reads" for All Barcodes
10 in Population
11 Standard Deviation of RDRRs
P-Value of the RDRRs, Compared to Those of
12 the Wild-Type (Control) Barcode Population
Z-Score of the Average RDRR, Compared to
Those of All Other Barcode Populations in the
13 Matrix

This is the set of matrices generated by Giga-D for each category of variants. Here, “Bad Reads”
refers to those reads which have been identified as poor quality for one of any number of
reasons. These reasons include low Phred scores, unidentified driver or reporter types, driver or
reporter sequences with a number of mutations that exceeds the accepted limit, etc. “RDRR” is
the reporter to driver read ratio. Each matrix represents a collection of statistics calculated for
each super-population of reads grouped by barcode and by driver protein sequence in a
category.

The number of rows in each matrix is equal to the length of the wild-type driver amino acid
sequence (plus another row to accommodate representation of the stop codon). The number of
columns in each matrix is equal to the number of possible amino acids the protein could have at
each residue. Each cell represents a super-population of barcode groups. These matrices are
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converted into heatmaps by a separate R script (Gentleman & Ihaka, 1997). Heatmaps are
generated by one of two methods. In the first method, the cells in a heatmap represent only
barcode populations with a mutation that matches an amino acid at a given residue. In the
second method, the cells in a heatmap represent all barcode populations that have a matching
amino acid at a given residue, regardless of whether that amino acid is wild-type or not. Details
of the progression of the organization from barcode group to super-populations in categories
can be seen in Figure 2.2.5. Organization of heatmaps in the different variant characteristic
categories are presented later in Figures A1, A2, and A3.
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Figure 2.2.5: The progressive organization of the reads, barcodes groups, and super-populations
culminating in the placement of a statistical datum into a residue versus amino acid matrix.
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The program interprets the next generation sequencing reads in much the same way for the
CMD screen. Unlike in the driver mutagenesis screen, however, the CMD hexamers are sorted
into an adjacency matrix, a matrix of sequence relationships between all of the unique
hexamers (Figure 2.4.10, Figure A16). This entails comparing the sequences of each possible
pair of hexamers, one to one, and calculating an aggregate score of values based on the
differences in the sequences. In addition to this matrix, the program also exports an average
read ratio for each hexamer. The adjacency matrix is then read by a separate R script and used
to generate a network of nodes, each representing a separate hexamer (Figure 2.2.6). The color
of each node is determined by the hexamer’s read ratio, read from the other file (Figure
2.4.11).
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Figure 2.2.6: A diagram demonstrating how the adjacency matrix distance scores are calculated,
and how these distance scores are used in the creation of a network of hexamer nodes. For
each pairwise comparison of MD hexamers, all amino acids are compared, one to one from Nterminal side to C-terminal side, and each comparison is given a distance score. This distance
score is drawn from an adjusted substitution rate matrix (Figure A16). The distance score is
used to determine the length of the edge between each pair of hexamer nodes in the network.
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2.3 METHODS
2.3.1 Giga-G: Sequence Generation Program
The Giga-G program was written in Java using the Eclipse Java Integrated Development
Environment (IDE) (The Eclipse Foundation, 2012). GSTSGP, upon being executed in the
command line, including a GigaAssay type program mode flag which directs the program to use
a certain mode and which currently includes options for driver mutagenesis (as with the Tat
protein experiment) and the GigaAssay CMD screen. It then reads parameters from the
configuration file. These include wild-type protein sequences, along with other required
sequences for the GigaAssay driver and reporter reads. Once parameters have been set, the
program enters a loop, the number of iterations of which is determined by the number of
barcodes set by the user.
For each iteration, for however many iterations are required to process all reads, the program
iterates through the wild-type driver DNA sequence and changes pseudorandomly selected
characters, based on the user set per-base mutation chance, using an algorithm that utilizes
Java’s native “Math.random()” random number generator function (Figures A4, A5, A6) . This
process is repeated both for the reporter sequence with a different user-specified mutation
chance, and for all of the other elements within the driver and reporter read sequences.
Once it enters the loop, the barcode sequence for the current iteration is generated by again
using Java’s native randomization function and the integers 1 through 4 to represent each of
the 4 bases. The length of the barcode is user determined. This process is also used to generate
the C-terminal random oligomers for the GigaAssay MD screen.
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Once all sequences have been set for the current iteration, the number of driver and reporter
reads are determined at random, using the same randomization algorithm (Figure A5). Here the
minimum value in the algorithm is either 0 or 1, depending on whether the user allows the
generation of “orphan” barcodes, which have no driver reads but one or more reporter reads.
The maximum value, equal to the maximum possible number of a given read type, is set by the
user as well. Read orientation (whether a read is the forward coding sequence, forward
complement, reverse coding sequence, or the reverse complement) is pseudorandomly
determined as well. Individual element sequences are then generated through
complementation and sequence reversal, as necessary. Complete read sequences are then
generated through the concatenation of constituent elements.
The program then generates a string of Phred score glyphs equal in length to each of the reads.
The chance of having a total average Phred score (with default average value of 90) per read is
user set and ultimately determined by the randomization algorithm.
The final step in the greater for loop is to write all reads to a FASTQ file. The name of each read
includes the read type (including protein name), orientation, number of altered bases in the
protein DNA sequence, barcode ID number (for the entire test file), overall sequence ID
number, sequence ID for its particular barcode. Following this, the program moves to the next
iteration in the loop and the whole process starts anew.
Once every set of reads for the specified number of barcodes have been written, the program
repeats the process for the user set number of “positive control” barcode read sets, where only
wild type sequences are used.
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The user can also choose to introduce negative controls by setting the probability of various
events, such as severely truncated driver or reporter sequences, truncated barcode sequences,
and missing elements.
2.3.2 Giga-D: GigaAssay Sequence Analysis Software Driver Mutagenesis Mode
The GigaAssay sequence analysis software currently has two settings for GigaAssay
experiments. It has Giga-D for the driver mutagenesis experiments and Giga-MD for the
GigaAssay MD screen. For either setting, the program initially processes input file the same
way.
Either Giga-D or Giga-MD begin by parsing command line statements for program setting flags
and input file paths. It then reads parameters, including wild type driver and reporter DNA and
amino acid sequences, from the configuration file. It reads the FASTQ file and, given that the
beginning of the four lines of information for each read is delineated by a “@” or “>” character,
parses each set of lines into a “GigaRead” object (Figure A7), which contains fields for the read
name, sequence, and string of Phred score glyphs, along with many other fields for use in later
stages of the program.
The program searches through each read for driver sequences, reporter sequences, and the
other necessary elements of the GigaAssay construct, including the barcode sequence, which is
itself identified using the boundaries of other elements. If the boundary of the nearest element
to the barcode sequence cannot be found, the program moves to the next nearest element in
the sequence and tracks back based on the missing element’s assumed length, and so on.
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Using Java’s native string matching functions, the program searches through each sequence for
the GigaAssay driver protein DNA sequence (in every orientation) in short substrings. If the
program does not find the first 15 bases of the driver sequence in the read, then it moves to
bases #2-16, and so on. While the substring length is user defined, the default length for the Tat
driver mutagenesis experiment is 15 bases because it allows for the proper identification of
driver sequences that contain up to 16 mutations, while still unambiguously identifying
sequences that only match the reference. In the event that a matching substring is found, the
assumed index of where the driver sequence begins is calculated from the indices of where the
substring begins in both the read sequence and the reference wild type sequence (Figures A8,
A9). For example, if the matching sequence of 20 bases is found starting at base 30 within the
reference sequence and base 60 within the experimental read sequence, the program sets the
experimental read’s driver start sequence as base number 30.
The program then analyzes the substring defined by this starting index and where the possible
driver sequence should end, the index of which is equal to the starting index plus the length of
the wild type driver. This sequence is then compared, base to base, with the wild type sequence
in order to determine how many mismatches exist between the two. If the number of
mismatches doesn’t exceed the user-defined maximum allowed number of mutations in order
to be counted as the prospective read type, the read’s driver element object, “Driver,” (A10) is
flagged, via a Boolean value, as being of that read type.
This is process is repeated for the reporter protein reference sequence. Once this is completed
and the driver/reporter type and orientation has been determined for all reads, any reads left
without a type are flagged as being low in quality and a specific error code is added to a list for
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manual inspection. The program continues, finding the proper forward coding driver or
reporter DNA sequence for the read, given its original sequence. The forward coding sequence
(the sense DNA sequence of the gene from which directly corresponds to the mRNA codons) is
then translated into its amino acid sequence. The program compares this to the reference
amino acid sequence, and information from both is added to an array of objects of the type,
“CompareSequenceAA,” which contains fields for the reference amino acid, read amino acid,
reference codon, and read codon, along with flags for amino acid type, and whether the codon
or amino acid are mutated (A11).
Additional sequence elements within each read are analyzed, and several other quality checks
are made, with appropriate additions to the error code lists for each. This includes the
calculation of an average Phred score for the sequence of interest, which includes all relevant
sequence elements, as per the method mentioned in Chapter 1.
Upon completion of this set of tasks, all “GigaRead” objects are sorted into a Java HashMap,
using the barcode sequence as a key. A new Java object is created for each barcode entry in the
final HashMap. This object is named “GigaVariant” to avoid confusion with the “Barcode”
element object. The list of “GigaRead” objects that share the unique barcode are added to a list
within “GigaVariant.”
The program then finds consensus driver sequences (both DNA and amino acid) for the list of
reads belonging to a “GigaVariant” object. Any conflicts are added to a list of indices of where
they fall in the sequence. Multiple error checks are performed to ensure that all relevant
elements in each set of reads match, and error codes are added to a list within “GigaVariant,”
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as needed. Error codes from subordinate reads are added to the list as well (Table 2.2). A TSV
file is generated, containing a table of barcodes with their associated consensus driver
sequences, error codes, mutations, and conflicts in the consensus.
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Table 2.2: Giga-D Error Codes and Error Sources
Type

Codes
specific
to
individua
l reads

Codes
specific
to
Barcode
Objects

Codes
Specific
to GigaMD

Code

Error Source

5

Phred Score < 30

6

Number of driver nucleotide mutations exceed given limit

7

Number of reporter nucleotide mutations exceed given limit

8

Reporter read with no reporter sequence

9

Driver read with no driver sequence

10

No barcode sequence found for read

11

Read contains both driver protein and reporter sequences

19

Reads has no type, and no driver or reporter sequence

33

Insertion in driver sequence

34

Deletion in driver sequence

35

Reporter sequence contains a premature stop codon

36
12
13

Insertion in driver sequence
Orphan Barcode (sequences containing this barcode either have no driver or reporter
sequences)
Barcode has no driver reads

14

Barcode has no reporter reads

20

Reads with this barcode contain differing driver DNA sequences

21

Reads with this barcode contain differing reporter DNA sequences

28

Reads with this barcode contain differing numbers of driver DNA mutations

29

Reads with this barcode contain differing numbers of driver DNA mutations

30

Reads with this barcode contain differing driver protein sequences

31
32

Reads with this barcode contain differing reporter protein sequences
Reads with this barcode differ on whether a truncation mutation exists within driver
sequence

38

Reads with this barcode contain differing driver DNA mutations

39

Reads with this barcode contain differing driver amino acid mutations

40

Reads with this barcode contain driver DNA sequences of different lengths

41

Reads with this barcode contain driver amino acid sequences of different lengths

42
43

Reads with this barcode differ on whether the driver DNA sequence contains an insertion
Reads with this barcode differ on whether the driver DNA sequence contains a deletion

44

Reads with this barcode differ on whether a premature stop codon exists within reporter
sequence

22

Reads with this barcode contain differing DNA MD sequences

47

Reads with this barcode contain differing MD haxamer sequences

48

Reads with this barcode have MD DNA sequences of different lengths

49

Reads with this barcode have MD AA sequences of different lengths

65
66

Reads with this barcode have different indices for the start of the MD sequence
Reads with this barcode have different indices for the end of the MD sequence
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A partial list of the error codes and corresponding error sources identified by the Giga-D
program.

This is the point at which the Giga-D diverges from Giga-MD. A search for the driver sequence
with the highest number of mutations is made. This number is saved for the next step, which is
copying the barcodes into different lists by category. A final category holding object, “Final,” is
created. “GigaVariant” objects are sorted into the following categories: all variants, all wild type
(zero mutation) variants, all non-wild type variants, all truncated variants. Additional categories,
non-wild type variants with n mutations and truncated variants with n mutations, are
generated for every number n from 1 (or 0, if no mutated reads exist) to the maximum number
of mutations found.
Within these categories, the variant objects are further sorted into arrays of “Residue” objects.
The Giga-D creates an array of “Residue” objects (A11), and an array of “ResidueCodon” (A12)
objects. These arrays have an identical size, equal to the length of the driver protein’s amino
acid sequence plus one. (The additional object is included to represent the stop codon in the
reference sequence). Each “Residue” object contains 26 “AminoAcid” objects, one for each
amino acid plus another for the stop codon, and another set of 5 objects for aggregated amino
acid and truncation types. Each “ResidueCodon” object contains 64 “AminoAcid” objects,
representing each possible codon. “AminoAcid” objects in turn contain fields for lists of
variants, and all statistical values to be calculated in the next step (Figure A13).
Variants are sorted into the lists within “AminoAcid” objects by what amino acid or codon they
contain at a given residue in the protein sequence. For example, a variant with an arginine at
the 12th residue and serine at the 25th residue would be added to the variant lists of both the
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“arg_R” and “ser_S” “AminoAcid” objects, in the 12th and 25th members of the “Residue” array,
respectively.
Statistical values are then calculated for each “AminoAcid” object in each residue array. In
order to do this, Giga-D first calculates the total number of driver, reporter, and poor quality
reads for all variants in each list. It then calculates the averages of each of these per barcode.
Using the total number of drivers and reporters, an average reporter over driver ratio is
calculated for each “AminoAcid” object. This average is used, in conjunction with the individual
reporter to driver ratios for each variant, to calculate a standard deviation and variance. The
program sets aside the reporter to driver ratio, standard deviation, and variance of the wild
type only variant list. These numbers, which are identical for every “AminoAcid” object in the
wild-type only category of “Residue” or “ResidueCodon” object arrays, are used in every
calculation for “AminoAcid” object p-values. All ratios within a single array of
“Residue”/”ResidueCodon” objects are used to calculate a Z-score for each subordinate
“AminoAcid” object.
Finally, Giga-D outputs data from each “Residue”/”ResidueCodon” array to comma-separated
values (CSV) files as matrices which will be imported by an R script, Giga-DH, and transformed
into heatmaps. Each member of each set of 13 “heatmap sets” is written to 2 files, one
including the data from wild type amino acids, and one excluding it (Figures A1, A2, and A3).
Each row of a matrix represents a residue in the mutagenized driver sequence and each value in
the row represents the statistical value from an “AminoAcid” object. Both two-dimensional and
one-dimensional matrices are generated, as one-dimensional matrices are required to
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represent the aggregated amino acid type and truncation only data. The file path, intended
heatmap name, and intended heatmap file path are written to a separate metadata file as well.
Diagrams showing the data organization from reads up to the final data holding object can be
seen in Figures A14 and A15.
Giga-DH uses the metadata file to import each matrix. The matrix is then transformed into a
heatmap via the R libraries, “ggplot2” (Wickam, 2013), “RColorBrewer” (Neuwirth, 2014),
“scales” (Wickam, 2017), and “reshape2” (Wickam, 2016). Each heatmap is labelled with the
appropriated title and file name, and output to PDF.
2.3.3 Statistics
The control group of barcode populations is found by identifying the “GigaVariant” objects with
wild type driver sequences. Once all of these have been identified, a list of the read ratios for
these variants is made. The mean and standard deviation of the control group is calculated
from this list. This list will be used to calculate a matrix of p-values for each
“Residue”/”ResidueCodon” array. Since the control populations share the same values
regardless of which wild type “AminoAcid” object they belong to, the control values are
uniform throughout arrays and therefore only need to be calculated once. The “GigaVariant”
read ratios in every “AminoAcid” object are saved to a list of values. The mean and standard
deviation are calculated for each list. P-values for each cell in the heatmap are then calculated
using Welch’s t test, the calculated degrees of freedom, and a t-table (Casella & Berger, 2002).
All populations are assumed to be of unequal variance.
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Equation 1: Calculation of Standard Deviation:

𝜎𝐶𝑜𝑛𝑡𝑟𝑜𝑙 (𝑊𝑖𝑙𝑑 𝑇𝑦𝑝𝑒 𝐵𝑎𝑟𝑐𝑜𝑑𝑒𝑠)

∑𝑁
(𝑥𝑖 − 𝑥̄ )2
𝑖=1
=√
𝑁−1

𝜎𝐶𝑜𝑛𝑡𝑟𝑜𝑙 (𝑁𝑜𝑛−𝑊𝑖𝑙𝑑 𝑇𝑦𝑝𝑒 𝐵𝑎𝑟𝑐𝑜𝑑𝑒𝑠)

2
∑𝑁
𝑖=1(𝑥𝑖 − 𝑥̄ )
√
=
𝑁−1

Where N is the number of read ratios in a group, xi is the read ratio of a given iteration through
the group, x̄ is the mean read ratio value of the group, and σ is the standard deviation.

Equation 2: Welch’s t-test:

𝑡=

(𝑥̄ 𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡 − 𝑥̄ 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 )
2
2
𝜎𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡
𝜎𝐶𝑜𝑛𝑡𝑟𝑜𝑙
√
+
𝑁𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡 𝑁𝐶𝑜𝑛𝑡𝑟𝑜𝑙

Where NExperiment is the number of read ratios in the non-control population group, NControl is the
number of read ratios in the control population list, x̄Experiment is the mean read ratio value of the
non-control group, x̄Control is the mean read ratio value of the control group, σControl2 is the
variance of the control group, and σExperiment2 is the variance of the non-control group.
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Equation 3: Degrees of Freedom (df)

𝑑𝑓 ≈

2
2
𝜎𝐸𝑥𝑝
𝜎𝐶𝑜𝑛
(
+
)2
𝑁𝐸𝑥𝑝 𝑁𝐶𝑜𝑛
4
4
𝜎𝐸𝑥𝑝
𝜎𝐶𝑜𝑛
+
2
2
𝑁𝐸𝑥𝑝
(𝑁𝐸𝑥𝑝 − 1) 𝑁𝐶𝑜𝑛
(𝑁𝐶𝑜𝑛 − 1)

Where df is the degrees of freedom, NExp is the number of read ratios in the non-control
population group, NCon is the number of read ratios in the control population list, σCon2 is the
variance of the control group, and σExp2 is the variance of the non-control group.

Equation 4: Z-Scores
Z-scores were derived by finding the mean and standard deviation for all (non-null) values
within a read ratio matrix and then subtracting the mean from each value and dividing by the
standard deviation.

𝑍=

(𝑥𝐶𝑒𝑙𝑙 − 𝑥̄ 𝑀𝑎𝑡𝑟𝑖𝑥 )
𝜎𝑀𝑎𝑡𝑟𝑖𝑥

𝜎𝑀𝑎𝑡𝑟𝑖𝑥

2
∑𝑁
𝑖=1(𝑥2 − 𝑥̄)
√
=
𝑁−1

Where xcell or xi is a given value of a cell within a read ratio matrix, x̄matrix is the mean value for
all cells in the matrix, N is the number of cells, σMatrix is the standard deviation for all cells in the
matrix, and Z is the Z-score of an individual cell.
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Equation 5: Calculation of predicted number of variants
𝐿!

𝑉𝐻 = 19𝐻 [(𝐿−𝐻)!𝐻!]
Where VH is the number of variants, H is the Hamming Distance, or number of mutations
required to get from one sequence to another. (Bosley & Ostermeier, 2005). L is the length of
the protein sequence.

2.3.4 Giga-MD: Software for the GigaAssay Minimotif Decoy (MD) Screen
The GigaAssay MD mode of the GigaAssay software, Giga-MD, analyzes reads in nearly the
same way as in the driver mutagenesis mode, up until the previously mentioned point of
divergence, when in the latter setting the variants are sorted by driver mutation. However, in
the process of identifying the driver sequence, here the software searches for the CMD element
sequence, located immediately downstream (on the 3’ side) of the driver protein.
As the CMD sequence is entirely random, its sequence is identified by using the bounds of other
sequence elements in the driver read. The experimental length of the CMD DNA sequence is set
by the user in the configuration file. Any deviations of the length of the recognized sequence
cause an error code to be added to the error code list. The CMD forward coding sequence is
translated to the string of appropriate amino acids. For each read, a “CMD” object is created,
where both the DNA and amino acid sequences are stored.
Once the “GigaRead” objects have been sorted into “GigaVariant” objects, an additional check
is performed to verify the consensus CMD sequence, in addition to the quality checks
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mentioned in the driver mutagenesis section. Giga-MD also searches for known minimotifs
within the CMD sequence.
“GigaVariant” barcode objects are then sorted, in a HashMap, by CMD amino acid sequence. An
average reporter to driver ratio is calculated for each unique CMD sequence, using the total
count of driver and reporter reads for every matching barcode object. The total numbers of
driver, reporter, and bad reads and matching known minimotifs for each sequence are output
to a TSV file for visual analysis by the user. The CMD sequence and reporter to driver ratio are
saved for further use in an R script in a separate CSV file.
An adjacency matrix is then generated by calculating a substitution score for each pair of CMD
sequences. The scoring system used is an altered PAM 250 log odds substitution matrix
(Dayhoff et al., 1978), where all values have been adjusted to be integers between 0 and 18
(A16). This score is calculated by comparing amino acids to each other one at a time, starting
from the 5’ end. The sum of these comparisons is calculated, and added to a two-dimensional
array. Once all values in the array have been calculated, the array is written to a CSV file, in the
form of an adjacency matrix.
This adjacency matrix, along with the file containing the CMD ratios, is read by a separate R
script, Giga-MD-2. This script, utilizing the R library, “igraph,” transforms the adjacency matrix
into a hexamer network graph, with each node representing a unique CMD sequence. Before
the graph is rendered, the label for each node is set as the amino acid sequence and the node
color is set, on a gradient between red and green, based on the matching reporter to driver
ratio. Network edges can optionally be labelled with adjacency matrix scores for the connected
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pairs of nodes, but given that this greatly reduces the clarity of the graph, this setting is not
currently used. The rendered graph is then output to an image file.
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2.4 RESULTS
2.4.1 GigaAssay Driver Mutagenesis Sequence Generation and Interpretation
Giga-G, when set to generate 1,005 groups of reads (each with 0 to 200 wild type driver and
reporter reads) sharing the same barcode sequences, correctly generated sequences in 99.3 %
of reads. This was calculated using an intermediate read analysis report generated by the GigaD (Figure 2.4.1), and by visually validating reads at random (Figure 2.4.2). The program also
identified 12 more barcode sequences than actually existed within the file. CSV matrix files
were also verified through visual analysis. All files were written with only cells corresponding to
wild type driver residues having non-null values (Figure 2.4.3). These files were then converted
into heatmaps by the GigaAssay Heatmap Generation R script (Figure 2.4.4).

Figure 2.4.1: An intermediate metrics report generated by Giga-D after sequence analysis of all
reads and sorting of all reads by barcode.
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Figure 2.4.2: Example output sequences generated by Giga-G, visually analyzed for correct
sequence generation. Portions of sequences have been redacted in compliance with the
researchers’ NDA. Barcode sequences are located within the redacted portion of the reads. (A)
An example of a driver read, with the DNA sequence of tat highlighted in blue. (B) An example
of a reporter read, with the DNA sequence of GFP highlighted in green.
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Figure 2.4.3: Portion of the read ratio, all variant category matrix file, represented in Excel. Only
cells for wild type Tat amino acid residues Met1, Val4, Leu8 have non-null values. Each row
represents a residue within the driver amino acid sequence, and each column represents an
amino acid.
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Figure 2.4.4: The all variants category read ratio heatmap generated by the GigaAssay R script
using the wild type driver sequence test file. Wild type residues are shown here in blue,
corresponding to a read ratio of 1.68 for all heatmap cells. Black cells correspond to null values.
Driver protein residues are shown along the y-axis, and the possible amino acids and stop
codon are shown along the x-axis. Two of Tat’s secondary structures are also shown along the
y-axis to the left (Bayer, et al., 1995) (Tahirov et al., 2010). This heatmap was generated with
simulated data.
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Figure 2.4.5: The all variants category read ratio heatmap generated by the GigaAssay R script
using the wild type driver sequence test file, broken down by codon. Wild type residues are
shown here in blue, corresponding to a read ratio of 1.68 for all heatmap cells. Black cells
correspond to null values. Driver protein residues are shown along the y-axis, and the possible
codons are shown along the x-axis. Two of Tat’s secondary structures are also shown along the
y-axis to the left. This heatmap was generated with simulated data.

Once the software had been validated with wild type reads, Giga-D was tested using a
simulated data file of 1000 barcode groups with mutated driver and reporter sequences, and 5
barcode groups with only wild type sequences (the control group). While all reads within a
barcode group shared the same driver sequence, each base within the sequence was generated
with a 0.13% chance of mutation, to reflect the observed mutation rate of the error prone
polymerase used in the driver sequence mutagenesis protocol. While mutation of the reporter
sequence is not the current focus of the GigaAssay driver mutagenesis experiments, it was still
necessary to verify the program’s ability to identify non-wild type reporter sequences. The
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chance to have a single mutation within the reporter sequence was set at 1%. Giga-D found
only 1337 reads out of 114064 (1.4%) with either no identifiable type, a barcode that was
truncated or absent, or both (Figure 2.4.6). The program also falsely identified 10 more barcode
sequences, as there were only 1,005 unique barcode sequences to be found within the test file.
The heatmaps generated from this analysis can be seen in Figure 2.4.7 and Figure 2.4.8. There
are additional example heatmaps in the appendix (Figure A17 through Figure A19).

Figure 2.4.6: An intermediate metrics report generated by Giga-D after analysis of the driver
mutagenesis test sequences.
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Figure 2.4.7: The all variants category read ratio heatmap generated by Giga-DH using the
driver mutagenesis test file. Cells are colored according to read ratio values, as defined by the
legend on the right. Red hues indicate a lower reporter to driver ratio, and blue hues indicate a
higher read ratio. Black cells correspond to null values. Driver protein residues are shown along
the y-axis, and the possible amino acids and stop codon are shown along the x-axis. Two of
Tat’s secondary structures are also shown along the y-axis to the left. This heatmap was
generated with simulated data.
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Figure 2.4.8: The all variants category read ratio heatmap generated by Giga-DH using the
driver mutagenesis test file, broken down by codon. Cells are colored according to read ratio
values, as defined by the legend on the right. Red hues indicate a lower reporter to driver ratio,
and blue hues indicate a higher read ratio. Black cells correspond to null values. Driver protein
residues are shown along the y-axis, and the possible codons are shown along the x-axis. Two of
Tat’s secondary structures are also shown along the y-axis to the left. This heatmap was
generated with simulated data.

2.4.2 GigaAssay Minimotif Decoy (MD) Assay Sequence Generation and Interpretation
Giga-G generated 1,005 barcode groups for interpretation by Giga-MD. The analysis software
incorrectly identified 12 extra unique barcode sequences. The program also identified 1,303
reads out 114,626 (1.1%) as having barcode sequences that were either missing or were an
incorrect length (Figure 2.4.9). The program generated an adjacency matrix CSV file (Figure
2.4.10) and a read ratio CSV file for the 999 unique amino acid hexamer sequences that it
identified (Figure 2.4.11). These files were used as inputs in Giga-MD-2, the GigaAssay MD
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hexamer network graph rendering R script. The graph was then exported to a PNG file (Figure
2.4.12).

Figure 2.4.9: An intermediate metrics report generated by the Giga-MD after analysis of the
simulated CMD sequences.

Figure 2.4.10: An example portion of the GigaAssay MD hexamer adjacency matrix produced by
Giga-MD, shown in Excel. The values of each cell correspond to the distance score for each pair
of hexamers. The character ‘!’ indicates a stop codon.
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Figure 2.4.11: An example portion of the GigaAssay MD hexamer and read ratio file produced
by Giga-MD, shown in Excel. The left column shows the hexamer amino acid sequence, and the
right column shows the reporter to driver read ratio.
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Figure 2.4.12: A hexamer relationship network graph rendered by Giga-MD-2 using a small
portion of the adjacency matrix. Node colors are based on simulated read ratios. Node labels
represent the hexamer amino acid sequence, with the ‘.’ character representing the stop
codon. Node “r00” is an artifact of the graphing process.
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2.5 DISCUSSION
Visual verification indicated that Giga-G correctly composed driver and reporter sequences in
most observed cases. While errors created by the sequence generation program affecting the
validation of the sequence analysis program are still entirely possible, it’s not likely in the
majority of cases. One limitation is the program’s inability to create driver sequences that differ
from each other within a barcode group. Therefore, there is currently no way to test the
sequence analysis program’s ability to identify this sort of problem, even if the program does
currently have that function.
Giga-D, while functioning relatively well as a computational tool for our project (of course
taking into account that there is currently only synthetic data to work with), still requires quite
a bit of optimization, given that it identifies more than 1% of reads as having wrong sequences,
even when it is presented with only wild-type sequences. It’s likely that at least a portion of this
is due how long the random barcode sequence is. The program may be identifying the
sequences of other elements within the true barcode sequence of some reads, leading to a
much more truncated falsely identified barcode. It’s uncertain how much of a bias this will
produce in the final read ratios for each super-population, but it should be assumed to be more
than a negligible amount, so further work is needed to identify and correct errors.
In the case of Giga-MD, the Java program does correctly output the adjacency matrix and ratio
file with few errors. However, it currently lacks a sophisticated way of addressing stop codons
that appear within the hexamer. While it should mark higher distances for comparisons with
the stop codons and subsequent amino acids along the N-terminal to C-terminal comparison
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path, it currently only adds a higher distance score to the total for a pairwise comparison of
hexamers. Likewise, the program only calculates the distance score by comparing the hexamers
residue to residue, and not by calculating the total number of amino acids hexamers having in
common, regardless of orientation. This would likely be invaluable for determining the
relationship between the minimotifs and protein activity. There may be cases where the
orientation of the minimotif does not matter. Amino acid composition and richness may play a
part, but there is no way to examine that with the current model. Methods to produce an
adjacency matrix with more flexible distance scores will be written in the future.
The biggest problem with the GigaAssay MD Screen software lies not with Giga-MD, but with
the Giga-MD-2. The current package being used, though it was selected for its adequate ability
to convert adjacency matrices into network graphs, is not capable of changing the length of the
edges between nodes based on the adjacency matrix distance scores, rendering it somewhat
useless for the purposes of this technique. I am currently looking into writing scripts for yEd
Graph Editor (yWorks, 2012) for network visualization or generating Circos plots (Krzywinski et
al., 2009) instead.
Both Giga-D and Giga-MD do generate proper matrix files for most found categories, but
currently the software only analyzes sequences for two versions of the screen. In order to
accommodate new applications of the basic GigaAssay design to new experiments, the
software must become more adaptable.
The identification of insertions and deletions in the driver and reporter sequences are handled
very crudely at present. This could result in the program falsely labeling a sequence as having
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no driver or reporter type because it finds too many mismatches when comparing bases
downstream from the indel when comparing them to the reference. This process will be
changed in the future to include a Smith-Waterman (Waterman, Smith, & Bayer, 1976) local
sequence alignment algorithm, so gaps in sequences won’t result in false negative errors.
The GigaAssay itself has the potential to be applied to a large variety of protein function
screens. The most apparent use outside of what’s been described here is the potential to use
the driver mutagenesis screens to more deeply understand amino acid co-evolution. By
comprehensively screening so many protein variants, the most critical amino acids for
maintaining the shapes of protein confirmations can be extrapolated by comparing residues
where changes to amino acids do the most damage to protein activity with the secondary
structures of the protein. Additional functions will need to be written into the software in order
to properly visualize this, as currently, secondary structures have to be added to heatmaps in
image editing software. Amino acid co-evolution has great implications in the treatment and
prevention of viral infections, not only in the case of HIV-1, but in any pathogenic virus. For
example, x-ray crystallography data on the Influenza A hemaglutinin and neuraminidase
envelope proteins, which determine the virus’s ability to infect host cells, has yielded evidence
that these proteins have residues, such as HA C-55 and NM1 N557, that co-evolve together to
retain their pairings through different strains (Mintaev et al., 2014). While x-ray crystallography
has a low throughput rate, the GigaAssay certainly does not. The GigaAssay design is flexible
enough to easily be able to test amino acid co-evolution, and likely many more mechanisms
that have yet to be explored.
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CHAPTER 3: THE NUTRIGENETICS PROJECT SOFTWARE
3.1 ABSTRACT
Currently, the standard practice of giving human individuals dietary advice is to give global,
uniform suggestions, regardless of an individual’s particular genetic makeup. Our laboratory has
composed a dataset of nutritional suggestions for individual genetic variants. Each suggestion is
based on data from rigorously annotated published studies. The dietary changes that are
recommended have been clinically demonstrated, in those studies, to possibly reduce the risk
of a detrimental phenotype or possibly reduce severity of symptoms. I have written and
validated a suite of Java software which generates a personalized dietary recommendation
report for an individual, based on a commercially distributed personal genome file. The first
program in the suite, Nutrigen-D, builds a database of suggestions from our dataset, and from
the USDA Nutrient Database. The second program, Nutrigen-R, compares a user’s personal
genome file, finds genetic variants that match those within the database, and generates a
report listing dietary recommendations.
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3.2 INTRODUCTION
Many attempts have been made to apply broad, unspecific dietary recommendations to the
entire human population. These recommendations often fail to cause any significant change in
the health of those they are made to. This is especially problematic given that over a third of
the world’s population could be considered to be overweight or obese (Ng et al., 2014). This
can be for any number of lesser reasons for this failing, including non-compliance, but the most
significant reason is likely the erroneous assumption that there is a single, homogenous diet
that is effective for a very heterogeneous population.
In order to significantly and positively effect a change on an individual’s health, the unique
genetic profile of that individual must be considered. This is a reality that has only started to be
acknowledged in the last few decades. Studies that consider genetic differences as a factor of
determining dietary efficacy were only proposed starting in the 1960’s (Roper, 1960) and only
started to be conducted in earnest in the early 2000’s (Ordovas & Mooser, 2004). This has
eventually resulted in the creation of an entirely new field of precision medicine, nutrigenetics.
Nutrigenetics is the study of the effect of genetic variation on the response of phenotypes and
phenotypic risk to diet and dietary changes (Fenech et al., 2011).
Studies conducted in this field have yielded some very interesting insights into the relationship
between nutrition and genetics, both through case control studies and through clinical trials. A
2015 study of 738 individuals indicated that the single nucleotide polymorphism (SNP)
rs2301241 in the thioredoxin gene, TXN, was associated with abdominal obesity and that the
effect of this polymorphism could be modulated through higher vitamin E intake (Mansego et
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al., 2015). A promoter assay verified this result, as higher doses of vitamin E induced higher
expression of TXN. A recent clinical study found that individuals with certain polymorphisms,
rs41283238C>G and rs670, in the apolipoprotein C-II (APOC3) and apolipoprotein A-I (APOA1)
genes were significantly more effected by high glucose and fat diets as a causal agent for
metabolic syndrome when compared to other genotypes (Hosseini-Esfahani et al., 2017).
Though there have been many nutrigenetics studies in recent years, they have yielded results
with limited utility for the average individual. This is a major limitation of currently available
nutritional recommendations. Our laboratory has sought to rectify this by designing a system by
which an individual’s personal genome file, received from commercial services such as
23andMe (Eriksson et al., 2010) or Family Tree DNA (Family Tree DNA, 2001), may be matched
to dietary recommendations appropriate for the polymorphisms that they have.
By carefully annotating available literature, our laboratory has compiled a dataset consisting of
entries detailing single nucleotide polymorphism (SNP) and diet interactions (Nilsson et al.,
unpublished). These entries include SNPs that predict an individual’s risk of developing one or
more deleterious phenotypes, such as diseases. The entries also include recommendations for
dietary changes that have been demonstrated to have an ameliorating effect on these risks,
based on annotations of existing high quality publications of clinical studies. These range from
case-control studies testing the associations between intake of certain foods and nutrients,
such as the effect of folate on the disease risk of colon cancer (Cheng et al., 2015), to large
cohort studies with where the diets of large sample groups were compared to many different
measurements, such as insulin levels (Smith, et al., 2012). The dataset includes six types of
dietary recommendations, with categories for nutrient, food, food group, and endophenotype
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based recommendations. There are also categories for recommendations of whole diets, such
as the “Mediterranean diet,” and a category for recommendations that don’t fit the
characteristics of the other types.
In order to generate reports of matches between personal genomes file and entries in the
nutrigenetics dataset and make recommendations about specific food items, I wrote two Java
programs.
The first program, Nutrigenetics-D, organizes the nutrigenetics data and filters entries for
quality, compares them to the United States Department of Agriculture’s (USDA’s) Nutrient
Database for Standard Reference (USDA, 2016). Any entry that does not pass thresholds for
both the significance of the dietary item’s effect on disease risk and the size of the effect is not
included in the generation of the final dietary recommendation report. The entries which pass
are then compared against the USDA Nutrient Database, and serving portions for foods
matching the recommendations are calculated. All data is then written to MySQL (Oracle
Corporation, 2017) database tables to be interpreted by the next program.
The second program, Nutrigenetics-R, compares the contents of an individual’s personal
genome file and generates a report with personalized diet suggestions.
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3.3 METHODS
The nutrigenetics software consists of 2 separate programs. The first program utilizes the
SchillerLab nutrigenetics dataset and tables from the USDA National Nutrient Database (Figure
A20) to construct a MySQL database for reference by the second program, which generates a
series of dietary suggestions, based on an input genome file.
3.3.1 Nutrigenetics-D: The Nutrigenetics Database Builder
The nutrigenetics database builder program, Nutrigen-D, first reads imports all command line
settings, file paths, and configuration settings, before importing both the nutrigenetics dataset
(as either a TSV or a MySQL database), and the USDA database’s nutrient data(“NUT_DATA”),
nutrient definition(“NUTR_DEF”), food description (“FOOD_DES”), food serving weight
(“WEIGHT”), and food group definition (“FD_GROUP”) files (Figure A21).
Nutrigen-D then parses each USDA file into a separate array of Java objects. The objects in
these arrays are then associated in a single array, using food group codes (“Fd_GrpCd”), unique
food identification numbers (“NDB_No”), and nutrient identification numbers as keys. The
resulting array consists of individual food objects, with child objects for each constituent
nutrient and serving measurement (Fig A22).
The nutrigenetics dataset is also parsed into an array. Each line of this dataset, when presented
to the program as a TSV, starts with a series of ID numbers, by which multiple lines can be
associated as a single nutrigenetics entry object with the appropriate genotype and
recommendation item child objects (Fig A23).
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During this step, the program performs a number of quality checks on the dataset. The first
check sets Boolean values for the quality of each recommendation. Any recommendation with
either a p-value exceeding 0.05 or an odds ratio between 0.8 and 1.2 is not included in the final
analysis. Duplicate variant entries that include the same variant-risk phenotype combination
are consolidated (if their p-values are below the threshold of acceptance and their odds ratios
fall outside of the exclusion range). Upper and lower ranges of confidence intervals are
averaged, as are odds ratios and p-values. This is done in order to have a single, simple
reference in the database (the original values are retained in a separate field of the final
database, labeled by source and separated by semicolon).
The database creation software then iterates over the array of nutrigenetics entries and
searches through the USDA nutritional database array (which has been sorted into a hash map
for faster processing) for matching foods, nutrients, or food groups, depending on the
recommendation type. Information from any matching nutritional entries are then copied into
the nutrigenetics array as instances of child classes.
The program then calculates daily serving amounts for each food/nutrient/food group using the
information from both datasets. The amount of any nutrient of interest per 100 grams of a
given food (originally taken from the USDA file “NUT_DATA,” field “nutri_Val”) is converted to
grams using the corresponding unit of measurement from the USDA file “NUTR_DEF” and field
“units”. Percent amount of nutrient by food mass is then calculated from this given nutrient
content. This is then multiplied by the serving weight of the food in grams to find the nutrient
amount per serving.
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To find the number of servings of food required to reach the daily recommended amount in the
nutrigenetics database, the recommended amount of nutrient/food/food group must be
calculated in grams. Many entries in the database are already available as gram value per day,
but recommendations exist in the form of percent energy intake per day. To ascertain what this
amount is in grams, an estimate of total grams of food consumed per day has been calculated
based on a 2000 dietary calorie per day diet (as recommended by the USDA 2010
recommended serving suggestions and the USDA Food Guidelines (USDA, 2010). This equates
to an estimated 1178 grams per day. Using this, the recommendation amount is calculated in
grams, and the number of servings required is found by dividing this by the nutrient amount per
serving of food. The recommended number of units of food are then derived from the food
serving units of measurement and amount of units per serving found in the USDA database
(fields “Gm_weight” and “Amount” in “WEIGHT”).
The nutrigenetics object array is then stored in a final SQL database using the MySQL™ Java
Connector JDBC Driver (Oracle Corporation, 2017). Entries are input into four tables,
“NutrigeneticsEntry,” “Genotype,” “Recommendation,” and “FoodNutrient” (Figure A24).
3.3.2 Nutrigenetics-R: The Nutrigenetics Personalized Diet Report Program
This database is then read into a hash map by the second program, Nutrigenetics-R, when a
user’s genome file is to be analyzed. The program then parses the user’s file and compares
either Reference SNP Cluster IDs or, when none are included, chromosome/position
combinations to find variants matching those in the database. Each matching entry is saved in
an object array, which includes both the user’s RSID and genotype information, as well as all
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food information from the database. Once all matching entries have been found, a summary of
dietary recommendations is created by consolidating duplicate food and nutrient
recommendations. Any recommendations that with conflicting directions are excluded from
this summary, and from the final report. The summary and matching entries, recommended
servings for the 5 most nutrient rich foods for each recommendation, are output to a PDF file
using the Apache PDFBox® Java PDF creation library. This information is also output to a text
file. The user’s anonymous ID number is then stored in the SQL database in a separate table
“User” and the user’s matching RSIDs and genotypes are stored in the table “UserEntry.”
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3.4 RESULTS
The performance of Nutrigenetics-D was validated through code execution tracing and directing
the program to write the results of certain methods to text files for visual analysis by the user.
When provided with the necessary input files from the USDA Nutrient Database (Figure 3.4.1)
and the Nutrigenetics dataset (FIGURE 3.4.2), the program accurately parses and associates
them in object arrays, from which information is then written to tables in a MySQL database.
This can be verified through the TSV generated through the importing of this information back
in from the four newly created tables, “NutrigeneticsEntry,” “Genotype,” “Recommendation,”
and “FoodAndNutrient” (Figure 3.4.3 to 3.4.7).

Figure 3.4.1: Partial sample of the USDA “NUT_DATA” input file, adapted from the USDA
Nutrient Database (CITATION). All other USDA files contain the same formatting. All values are
separated by the character pattern ‘~^’ or ‘^’. All information about the specific value types can
be found in the documentation of the current release (SR28) of the USDA National Nutrient
Database for Standard Reference (CITATION).
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Figure 3.4.2: General format of the Nutrigenetics dataset input TSV file. This sample includes
only simulated and redacted data in order to protect information in compliance with the NDA.
The first line of the file includes the header, a tab separated list of the names of the columns in
the file. Following lines correspond to entries in the dataset, where the first value in the line
represents an entry identification number, and the following 3 values indicate the genotype
and recommendation information lines for that entry. Lines are demarcated by the numbers in
the gray bar.

Figure 3.4.3: Sample portion of the “NutrigeneticsEntry” table validation output TSV file
generated by the Nutrigenetics Database Creation Program. This sample contains only
simulated dataset information in compliance with the researchers’ NDA. The first line of the file
indicates the column names for the following lines in the file. Lines are demarcated by the
numbers in the gray bar.
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Figure 3.4.4: Sample portion of the “Genotype table validation output file generated by the
Nutrigenetics Database Creation Program. This sample contains only simulated dataset
information in compliance with the researchers’ NDA. The first line of the file indicates the
column names for the following lines in the file. Lines are demarcated by the numbers in the
gray bar.

Figure 3.4.5: Partial sample of the TSV file corresponding to the data in the “Recommendation”
table generated by the Nutrigenetics Database Creation Program. Sensitive information
regarding each entry has been redacted in compliance with the NDA. The first line of the file
indicates the column names for the following lines in the file. Lines are demarcated by the
numbers in the gray bar.
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Figure 3.4.6: Partial sample of the TSV file corresponding to the data in the “NutrientNumber”
table generated by the Nutrigenetics Database Creation Program. This sample contains only
simulated dataset information in compliance with the researchers’ NDA. The first line of the file
indicates the column names for the following lines in the file. Lines are demarcated by the
numbers in the gray bar.

Figure 3.4.7: Partial sample of the TSV file corresponding to the data in the “FoodAndNutrient”
table generated by the Nutrigenetics Database Creation Program. This sample contains only
simulated dataset information in compliance with the researchers’ NDA. The first line of the file
indicates the column names for the following lines in the file. Lines are demarcated by the
numbers in the gray bar.

Once it had been verified that Nutrigenetics-D correctly generates the MySQL database,
Nutrigenetics-R was validated through the input of several different genome file formats,
“23AndMe” (Erikkson et al., 2010), VCF (IGSR, 2017), and “Diagnomics” (Diagnomics, 2016)
(Figure 3.4.8-3.4.10).
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Figure 3.4.8: Sample “23AndMe” input file, with rsID, chromosome, position, and genotype
columns. Values have been partially redacted to protect personal information.

Figure 3.4.9: Sample VCF input file, with chromosome, position, rsID, reference allele, alternate
allele, quality score, and other assorted columns. Values have been partially redacted to protect
personal information.

Figure 3.4.10: Sample “Diagnomics” input file, with rsID, chromosome, position, genotype, and
other assorted columns, Values been partially redacted to protect personal information.
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The NPDRP correctly generated reports for each, though the program does generate some very
similar, almost duplicate suggestions. This is due to the current lack of an algorithm to
consolidate entries with separate rsIDs but identical risk phenotypes. Additionally, in the case of
nutrient based recommendations, the program currently has no filter for very similar food
suggestions and simply lists the most nutrient dense foods in descending order, leading in many
cases to the recommendation of foods all belonging to a very small category, such as “fish oil”
or “plant based cooking oils.” Examples of the summary and detailed suggestions in the reports
can be seen in Figure 3.4.11 and Figure 3.4.12. Data correlating to the user specific MySQL
database table, “User,” can be seen in Figure 3.4.13.

Figure 3.4.11: Summary of dietary suggestions section of the personalized diet report returned
by Nutrigenetics-R.
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Figure 3.4.12: Sample portion of individual dietary suggestions section of the personalized diet
report returned by Nutrigenetics-R.

Figure 3.4.13: Sample portion of “User” table verification file. Columns have been re-aligned for
visual analysis, and sensitive information regarding each entry has been redacted in compliance
with the NDA.

Another test was also conducted to validate the program’s ability to correctly recognize
individual matching entries within the genome file. A short “23AndMe” file was constructed
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using only 3 rsIDs with matching (and 3 non-matching) entries in a version of the Nutrigenetics
database which contains only simulated, intellectual property free data (Figure 3.4.14). Using
this input, the program returned report files containing correct matching entries (Figure 3.4.15).

Figure 3.4.14: 23AndMe format test file for determining whether the NPDRP correctly identifies
matching personal genetic data file entries, by both rsID and genotype. The entries with
matching data are rs12564807, rs4439035, and rs7934469. Entry rs7934469 matches an rsID in
the database, but contains a genotype that is not relevant to the database entry. Entries
rs999999, rs8888888, and rs7777777 have no corresponding entries in the database.

Figure 3.4.15: The results inputting a short test file (Figure 3.4.14) into Nutrigenetics-R. (A) The
returned print statements for each matching entry found by the program. (B) The summary of
diet suggestions output by the program when given the test file as an input. Suggestions are
based on simulated data and do not reflect real suggestions in the Nutrigenetics dataset.
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3.5 DISCUSSION
The Nutrigenetics software accurately compiles and stores nutrigenetics dataset and USDA
Nutrient Database information, and correctly generates dietary suggestion reports for several
different personal genome file types. However, this software does have its limitations.
Currently, serving amounts for suggestions where the original suggested amount is noted as a
certain percentage of total energy per day are currently calculated with the estimated mass
consumed daily by an average individual. This is likely insufficient for two reasons. First, the
estimated mass is an aggregate of the proportions of different types of food (i.e. meat, dairy,
and vegetables) recommended by the USDA and calculated from the average mass of several
food items belonging to each group. Some foods may simply be more or less dense than others
within a given food group, causing this estimate to be very inaccurate. Also, risks phenotypes
may be listed multiple times within the detailed suggestions section of the reports, as the
report is sorted by polymorphisms, many of which carry risks for the same phenotypes. This
necessitates consolidation of entries. These limitations will be rectified in future releases of the
software.
The size of the current nutrigenetics dataset is also somewhat limited. More work will be done
to annotate more studies in the future, but it’s likely that a system such as this one requires
some automated processes to find and annotate studies without as much need for researcher
labor.
Despite these limitations, the software adequately generates reports such it can now be used,
in conjunction with a server to process numerous reports for many of the most widely used
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genome file formats, making it a very useful tool for aiding in the application of the field of
nutrigenetics’ knowledge to the everyday life of the individual.
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APPENDIX

Figure A1: Variant super-population categories and subordinate heatmap groups, for all
categories which include wild type amino acids. The asterisk (‘*’) represents the group of
heatmaps, as described in Figure A3.
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Figure A2: Variant super-population categories and subordinate heatmap groups, for all
categories which exclude wild type amino acids. The asterisk (‘*’) represents the group of
heatmaps, as described in Figure A3.
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Figure A3: The set of heatmaps generated for each category of variant in Figures A1 and A2.

Figure A4: The algorithm for determining whether a given base within the driver or reporter
DNA sequence will be “mutated”. For example: if the user determines that there should be a
1% chance of “mutation”, the user may set the value of “mutChanceDenom” to 100,000,000
and “driverPerBaseMutationChance” or “reporterPerBaseMutationChance” to 1,000,000
(100,000 divided by 100,000,000 is equal to 0.01, or 1% of the denominator). If the value of the
random number (between 1 and 100,000,000, inclusive of both limits) is equal or less than the
user set per protein mutation chance, the index of that base is added to a list of integers within
the protein entry object and the base is later changed to a different character (see Figure A6).
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Figure A5: The algorithm for selecting the pseudorandom value for the determination of
whether a given character is “mutated.” Here, “min” is the minimum possible value that can be
generated, “max” is the maximum possible value that can be generated, and “range” is the
difference between the minimum value and the maximum value, added to 1 to be inclusive of
the upper limit. The final pseudorandom value is an integer (data type “int” in Java) equal to
the base pseudorandom value generated by Java’s random number generation method,
multiplied by the range and added to the minimum possible value.
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Figure A6: The algorithm for pseudorandom determination of “mutated” bases. The variable
“refChar” refers to the original base in the wild type DNA sequence, and “nt” refers to the
returned base, post “mutation”. This algorithm pseudorandomly generates a number between
1 and three, each one of which corresponds to a different base not equal to that of the original
sequence.
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Figure A7: “GigaRead” Java object. This object contains all information for a given read analyzed
by Giga-D or Giga-MD.
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Figure A8: The protein sequence identification algorithm, which returns a temporary holding
object for the given read. Variables “seq” and “refseq” represent the whole read sequence from
the FASTQ file and the user supplied reference DNA sequence for the driver or reporter protein,
respectively. The variable “maxMut” is the maximum number of mutations allowed in a DNA
sequence in order to be counted as a given read type. Boolean variables indicate the
orientation of the reference sequence. This algorithm is nearly identical for reporter read
recognition, save for the appropriate variable names. See Figure A9 for information on the
returned object.

Figure A9: The temporary information holding Java object for the protein sequence
identification algorithm. Boolean values indicate found read type orientation, and “substring”
field represents the recognized driver sequence. This algorithm is nearly identical for reporter
read recognition, save for the variable names.
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Figure A10: The “Driver” Java object. This object holds information specific to the driver
sequence of a given read analyzed by Giga-D or Giga-MD. This object is nearly identical to the
“Reporter” object, save for appropriate variable names.
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Figure A11: The “CompareSequenceAA” object for storing information about individual amino
acids within both the read amino acid sequence and the consensus amino acid sequence for
each set of sequences with an identical barcode. Zigzag lines indicate omission of fields of the
same type.
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Figure A12: The custom Java objects (A) “Residue” and (B) “ResidueCodon.” Each object has an
“AminoAcid” child object for each possible amino acid (in the case of “Residue”) or codon (in
the case of “ResidueCodon”) along with additional objects for stop codons and amino acid
types.

Figure A13: The “AminoAcid” object contains fields for all necessary statistical values and a list
of all “GigaVariant” objects within the residue/amino acid super-population.
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Figure A14: Organization of the barcode super-populations down from the final dataset holding
object, down to the constituent reads of a barcode.
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Figure A15: Organization of the “Final” object and its subcategories for the sorting of barcode
super-populations. The “X” object in (A) represents the identical group of child categories in (B).
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Figure A16: The CMD scoring matrix for calculating distance scores between pairs of CMD
hexamers. Altered from the PAM250 log odds substitution matrix.
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Figure A17: The non-wild type variants category total read count heatmap generated by the
GigaAssay R script using the driver mutagenesis test file, broken down by codon. Cells are
colored according to read ratio values, as defined by the legend on the right. Black cells
correspond to null values. Driver protein residues are shown along the y-axis, and the possible
codons are shown along the x-axis. Two of Tat’s secondary structures are also shown along the
y-axis to the left. This heatmap was generated with simulated data.
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Figure A18: The truncated variants category driver read count heatmap generated by the
GigaAssay R script using the driver mutagenesis test file, broken down by codon. Cells are
colored according to read ratio values, as defined by the legend on the right. Black cells
correspond to null values. Driver protein residues are shown along the y-axis, and the possible
codons are shown along the x-axis. Two of Tat’s secondary structures are also shown along the
y-axis to the left. This heatmap was generated with simulated data.
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Figure A19: The truncated variants category driver read count heatmap generated by the
GigaAssay R script using the driver mutagenesis test file, broken down by codon. Cells are
colored according to read ratio values, as defined by the legend on the right. Black cells
correspond to null values. Driver protein residues are shown along the y-axis, and the possible
codons are shown along the x-axis. Two of Tat’s secondary structures are also shown along the
y-axis to the left. This heatmap was generated with simulated data.
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Figure A20: A Schematic of the full U.S. Department of Agriculture Nutrient Database, with
definitions and field information types (CITATION).

121

Figure A21: An abbreviated schematic of the U.S. Department of Agriculture Nutrient Database,
including only those tables and fields required by the nutrigenetics software.
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Figure A22: A schematic of the USDA data object array created by the nutrigenetics database
creation program. Each parent food object has one or more of each type of child object,
“Nutrient” and “Weight.”

123

Figure A23: A schematic of the nutrigenetics dataset object array, including the parent object,
“NutrigeneticsEntry,” and the child objects, “Genotype,” and “Recommendation.”
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Figure A24: A full schematic of the nutrigenetics MySQL database with all tables.
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Figure A25 A-B: A simplified diagram of how Giga-D processes NGS reads and generates variant
category statistical matrices for heatmap creation. A) Giga-D imports reads from the file and
identifies the type of each read. B) It then identifies the barcode sequence of each read and
sorts the reads into Barcode objects, based on those their barcode sequences.
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Figure A25 C: Giga-D identifies the consensus driver (and reporter) sequence for each group of
reads in a Barcode object. It then calculates the RDRR for each barcode group.

Figure A25 D: Giga-D sorts the Barcode objects into categories based on driver characteristics
(see Figures A2 and A3). For each category, each corresponding Barcode object is sorted into an
array of Residue objects. The size of the array is equal to the length of the driver protein plus 1.
Each Residue object has 21 AminoAcid objects, represented here as yellow “bins.”
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Figure A25 E: Within each Residue object, each Barcode object is sorted into the correct
AminoAcid object, shown here as yellow “bins.” This diagram shows one of the two sorting
methods performed by Giga-D, the “WT Amino Acid Excluding” method. Here, Barcode objects
are only sorted into an AminoAcid object “bin” if the amino acid at that locus in the Barcode’s
driver sequence is mutated, thereby excluding the wild-type amino acids. The other method is
the “WT Amino Acid Including” method, where Barcodes are sorted into “bins” based on their
driver protein sequence, regardless of whether or not the residues are wild-type.
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Figure A25 F: For each AminoAcid object, or “bin”, a number of statistical values are calculated
(see Table 3 or Figure A3 for a full list).
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Figure A25 G: The collection of each statistical value type is used to generate the matrices,
where each Residue object represents a row and each set of corresponding AminoAcid objects
represent a column (Figure 2.2.5).
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Table 2.3: Advantages and Disadvantages of Available Protein Function Identification
Techniques
Assay / Technique
Prediction of
function by protein
homology

Advantages
Simple, can often find accurate
predictions of protein functions
based on those of related proteins

Disadvantages
High error rate, Very similar proteins
may not share the same function, Not
validated by experimentation

Prediction of
function by
minimotif
identification

Minimotif functions are often
conserved, so predictions of
function may be very accurate

High false-positive rate, Not validated
by experimentation

Prediction of
function based on 3dimensional
structure

Can infer some protein function
based on 3-dimensional structure
and similarity to other proteins

High false discovery rate, Protein
conformations can often be transient,
inconsequential, and very numerous,
Not validated by experimentation

Can identify protein-protein
interactions, Relatively inexpensive

High false-positive rate, Cannot identify
non-protein-protein interactions, Labor
intensive, Time consuming, Unable to
detect trans-membrane protein
interactions, Identification of nonspecific interactions, Might detect
interactions in cellular compartments
to which proteins of interest are not
native, Cannot directly examine protein
function,

Can identify protein interactions in
vivo, reliable

High false-positive rate, Little ability to
detect transient or low-affinity
interactions, Cannot determine if
interactions are direct or indirect,
Labor intensive, Time consuming,
Requires very specific bait protein
antibody, Cannot directly examine
protein function, Identification of nonspecific interactions, Difficult to
optimize

Can infer protein function through
loss of activity

Can be difficult to infer specific protein
function when loss of function may
lead to multiple downstream effects,
Labor intensive, Time consuming,
Cannot directly examine protein
function

Yeast Two-Hybrid

Coimmunoprecipitatio
n

Site directed
mutagenesis
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Table 2.3: Advantages and Disadvantages of Available Protein Function Identification
Techniques (Continued)
Assay /
Technique

Advantages
Can identify protein-protein
interactions accurately

Disadvantages
Cannot directly examine protein
function, Low-throughput

Can identify protein-protein
interactions accurately

Cannot identify whether interaction is
direct or indirect, Results can be
confounded by nucleic acid
contamination, False-positives from
non-specific interactions, Cannot
identify non-protein-protein
interactions, Cannot directly examine
protein function

Chimeric
Minimotif Decoy
Assay

Can predict protein function,
Versatile

Medium-throughput, Possible high
false-positive rate due to ambiguous
fluorescence results, Possible high
false-negative results due to
interactions that are downstream of
reporter

GigaAssay Driver
Mutagenesis

Can predict protein domain function,
Very High-throughput, Can
comprehensively screen all variants
of a protein, Very sensitive
measurements of protein activity
level, Versatile

Possible reporter to driver read ratio
bias from RNA-Seq process, Expensive

GigaAssay
Minimotif Decoy
Screen

Can predict protein function, Very
High-throughput, Versatile,
Eliminates CMD screen false-positive
limitation

Possible reporter to MD read ratio bias
from RNA-Seq process, Expensive,
Possible false-negatives due to
interactions that are downstream of
reporter

PPiSeq

GST Pulldown
Assay

Sources: (Whisstock & Lesk, 2003), (Khan & Kihara, 2016), (Mi et al., 2011), (Yu et al., 2015),
(Lievens et al., 2013), (Chang & Siegel, 2000), (Schlecht et al., 2017), and (Nguyen & Goodrich,
2006).
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